RSK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00116 | S65 | Sugiyama | AGPS AAG5 | LLGRPREALSTNECKARRAAsAAtAAPtAtPAAQEsGtIPK |
| O00170 | S43 | Sugiyama | AIP XAP2 | GELPDFQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELI |
| O14649 | S393 | SIGNOR|EPSD|PSP | KCNK3 TASK TASK1 | sVsTGLHSLStFRGLMKRRssV___________________ |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15234 | T13 | Sugiyama | CASC3 MLN51 | ________MADRRRQRAsQDtEDEESGASGsDsGGsPLRGG |
| O15460 | S531 | Sugiyama | P4HA2 UNQ290/PRO330 | KWVSNKWFHERGQEFLRPCGstEVD________________ |
| O43175 | S12 | Sugiyama | PHGDH PGDH3 | _________MAFANLRKVLIsDsLDPCCRKILQDGGLQVVE |
| O43379 | S49 | Sugiyama | WDR62 C19orf14 | RGQssPPPAPPICLRRRtRLstAsEETVQNRVsLEKVLGIT |
| O43379 | T50 | Sugiyama | WDR62 C19orf14 | GQssPPPAPPICLRRRtRLstAsEETVQNRVsLEKVLGITA |
| O43707 | S423 | Sugiyama | ACTN4 | NEIRRLERLDHLAEKFRQKAsIHEAWtDGKEAMLKHRDyEt |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60825 | S466 | SIGNOR | PFKFB2 | RDKPTNNFPKNQTPVRMRRNsFtPLsssNtIRRPRNYsVGs |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O75369 | S1442 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | SKVKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGP |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75534 | T589 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRPLRSVD |
| O75582 | T700 | GPS6 | RPS6KA5 MSK1 | GLRYNEWLQDGSQLSSNPLMtPDILGSSGAAVHTCVKAtFH |
| O95831 | S116 | Sugiyama | AIFM1 AIF PDCD8 | NERIsGLGLtPEQKQKKAALsAsEGEEVPQDKAPSHVPFLL |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P01100 | S362 | GPS6|ELM|EPSD | FOS G0S7 | VFTYPEADSFPSCAAAHRKGsSsNEPSSDSLSsPTLLAL__ |
| P03372 | S167 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | ESR1 ESR NR3A1 | PAFYRPNsDNRRQGGRERLAsTNDKGSMAMESAKETRYCAV |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04632 | T85 | Sugiyama | CAPNS1 CAPN4 CAPNS | VIsAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLF |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05114 | S21 | SIGNOR|iPTMNet|EPSD | HMGN1 HMG14 | MPKRKVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAA |
| P05114 | S25 | SIGNOR|iPTMNet|EPSD | HMGN1 HMG14 | KVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAAKDKS |
| P05114 | S7 | SIGNOR|iPTMNet|EPSD | HMGN1 HMG14 | ______________MPKRKVssAEGAAKEEPKRRsARLsAK |
| P05198 | S52 | EPSD|PSP | EIF2S1 EIF2A | AYVSLLEYNNIEGMILLsELsRRRIRSINKLIRIGRNECVV |
| P05204 | S25 | SIGNOR|iPTMNet|EPSD | HMGN2 HMG17 | KAEGDAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAP |
| P05204 | S29 | SIGNOR|iPTMNet|EPSD | HMGN2 HMG17 | DAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAPAKKG |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05783 | S53 | SIGNOR|iPTMNet|EPSD | KRT18 CYK18 PIG46 | AsVyAGAGGsGsRIsVsRstsFRGGMGsGGLAtGIAGGLAG |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P05787 | S475 | Sugiyama | KRT8 CYK8 | TSSSRAVVVKKIETRDGKLVsEssDVLPK____________ |
| P05787 | S477 | Sugiyama | KRT8 CYK8 | SSRAVVVKKIETRDGKLVsEssDVLPK______________ |
| P05787 | S478 | Sugiyama | KRT8 CYK8 | SRAVVVKKIETRDGKLVsEssDVLPK_______________ |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P07101 | S40 | SIGNOR | TH TYH | ELDAKQAEAIMVRGQGAPGPsLTGsPWPGTAAPAASYTPTP |
| P07101 | S71 | SIGNOR|EPSD|PSP | TH TYH | APAASYTPTPRsPRFIGRRQsLIEDARKEREAAVAAAAAAV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | S880 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LKAQYKEKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08174 | S106 | Sugiyama | CD55 CR DAF | QWSDIEEFCNRSCEVPtRLNsAsLKQPYITQNyFPVGtVVE |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S482 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sGDEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVER |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P09496 | S236 | Sugiyama | CLTA | RLCDFNPKSSKQAKDVSRMRsVLIsLKQAPLVH________ |
| P09496 | S240 | Sugiyama | CLTA | FNPKSSKQAKDVSRMRsVLIsLKQAPLVH____________ |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10636 | T529 | EPSD | MAPT MAPTL MTBT1 TAU | GDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtP |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11362 | S789 | SIGNOR|EPSD|PSP | FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR | LSMPLDQysPsFPDTRsstCsSGEDsVFSHEPLPEEPCLPR |
| P12814 | S404 | Sugiyama | ACTN1 | NEIRRLERLDHLAEKFRQKAsIHEAWtDGKEAMLRQKDyEt |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13796 | S5 | EPSD|PSP | LCP1 PLS2 | ________________MARGsVsDEEMMELREAFAKVDtDG |
| P13798 | S8 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | _____________MERQVLLsEPEEAAALyRGLSRQPALsA |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S746 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GyLLPDTKAYGDRIERMLRLsLNIDPDAKVEEEPEEEPEET |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P16104 | S140 | GPS6 | H2AX H2AFX | KtsAtVGPKAPSGGKKAtQAsQEy_________________ |
| P16104 | S17 | GPS6 | H2AX H2AFX | ____MSGRGKTGGKARAKAKsRssRAGLQFPVGRVHRLLRK |
| P16220 | S119 | SIGNOR|PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16949 | S16 | EPSD|PSP | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P18615 | S113 | Sugiyama | NELFE RD RDBP | EGKLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLy |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18848 | S245 | GPS6|SIGNOR|ELM|EPSD|PSP | ATF4 CREB2 TXREB | PESYLGSPQHSPSTRGSPNRsLPsPGVLCGSARPKPYDPPG |
| P19105 | S19 | PSP | MYL12A MLCB MRLC3 RLC | __MSSKRTKTKTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19525 | T451 | SIGNOR|EPSD|PSP | EIF2AK2 PKR PRKR | GDFGLVtsLKNDGKRtRSKGtLRyMsPEQIssQDYGKEVDL |
| P22059 | T377 | Sugiyama | OSBP OSBP1 | NEFFDAPEIITMPENLGHKRtGsNIsGAssDIsLDEQyKHQ |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22736 | S351 | SIGNOR|iPTMNet|EPSD | NR4A1 GFRP1 HMR NAK1 | GMVKEVVRTDsLKGRRGRLPsKPKQPPDAsPANLLtSLVRA |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P25705 | S76 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | EERILGADtsVDLEETGRVLsIGDGIARVHGLRNVQAEEMV |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25963 | S32 | EPSD|PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26232 | S654 | Sugiyama | CTNNA2 CAPR | EELEDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQ |
| P26373 | S106 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | IHKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLIL |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P29317 | S897 | EPSD|PSP | EPHA2 ECK | APDSLKTLADFDPRVsIRLPstsGsEGVPFRTVsEWLESIK |
| P29401 | S104 | Sugiyama | TKT | AVWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGs |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P32314 | S365 | SIGNOR|EPSD|PSP | FOXN2 HTLF | EGFHSEEDTDVDYEDDPLGDsGYAsQPCAKISEKGQSGKKM |
| P32314 | S369 | SIGNOR|EPSD|PSP | FOXN2 HTLF | SEEDTDVDYEDDPLGDsGYAsQPCAKISEKGQSGKKMRKQT |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33778 | S33 | SIGNOR|EPSD | H2BC3 H2BFF HIST1H2BB | KGsKKAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDT |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35221 | S655 | Sugiyama | CTNNA1 | PEELDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQ |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35659 | S303 | Sugiyama | DEK | KKADSSTTKKNQNSSKKEsEsEDssDDEPLIKKLKKPPTDE |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S148 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | YDDPEVQKDIKNVPFKIVRAsNGDAWVEAHGKLYSPSQIGA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40763 | S727 | EPSD|PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P42566 | S746 | Sugiyama | EPS15 AF1P | DFSTLSKVNNEDPFRSATSssVsNVVITKNVFEETSVKSED |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P46527 | T198 | GPS6|ELM|EPSD | CDKN1B KIP1 p27 | sPNAGSVEQtPKKPGLRRRQt____________________ |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48764 | S663 | EPSD|PSP | SLC9A3 NHE3 | TEDEKQDREIFHRTMRKRLEsFKSTKLGLNQNKKAAKLYKR |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49792 | T3217 | Sugiyama | RANBP2 NUP358 | DTVKKIESFGsPKGSVCRRItITECGQI_____________ |
| P49840 | S21 | SIGNOR|EPSD|PSP | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S9 | GPS6|EPSD|PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51812 | S227 | iPTMNet|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | IKLTDFGLSKESIDHEKKAysFCGtVEYMAPEVVNRRGHTQ |
| P51812 | S369 | iPTMNet|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | GRPEDTFYFDPEFTAKtPKDsPGIPPsANAHQLFRGFsFVA |
| P51812 | S386 | GPS6|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | PKDsPGIPPsANAHQLFRGFsFVAItsDDESQAMQTVGVHS |
| P51812 | S415 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | ESQAMQTVGVHSIVQQLHRNsIQFTDGYEVKEDIGVGsysV |
| P51812 | S432 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | HRNsIQFTDGYEVKEDIGVGsysVCKRCIHKATNMEFAVKI |
| P51812 | S434 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | NsIQFTDGYEVKEDIGVGsysVCKRCIHKATNMEFAVKIID |
| P51812 | S708 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | YQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQ |
| P51812 | S715 | iPTMNet|EPSD|Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | APHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQRRGIKKI |
| P51812 | S724 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | AAtysALNRNQsPVLEPVGRsTLAQRRGIKKITSTAL____ |
| P51812 | T231 | iPTMNet|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | DFGLSKESIDHEKKAysFCGtVEYMAPEVVNRRGHTQSADW |
| P51812 | T365 | iPTMNet|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | KPATGRPEDTFYFDPEFTAKtPKDsPGIPPsANAHQLFRGF |
| P51812 | T581 | iPTMNet|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | DFGFAKQLRAENGLLMtPCytANFVAPEVLKRQGYDAACDI |
| P51812 | T706 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | PQYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTL |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P51858 | S107 | Sugiyama | HDGF HMG1L2 | WEIENNPtVKASGYQSsQKKsCVEEPEPEPEAAEGDGDKKG |
| P53355 | S289 | GPS6|ELM|EPSD|PSP | DAPK1 DAPK | SLQHPWIKPKDTQQALSRKAsAVNMEKFKKFAARKKWKQsV |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53621 | S266 | Sugiyama | COPA | RGHyNNVSCAVFHPRQELILsNsEDKSIRVWDMSKRTGVQT |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60174 | S195 | Sugiyama | TPI1 TPI | KtATPQQAQEVHEKLRGWLKsNVsDAVAQstRIIyGGsVtG |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P61024 | S39 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | yRHVMLPKDIAKLVPKTHLMsEsEWRNLGVQQsQGWVHyMI |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62304 | S89 | Sugiyama | SNRPE | KSRKQLGRIMLKGDNITLLQsVsN_________________ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62753 | S235 | GPS6|EPSD|PSP | RPS6 OK/SW-cl.2 | KRMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK______ |
| P62753 | S236 | GPS6|EPSD|PSP | RPS6 OK/SW-cl.2 | RMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK_______ |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | S102 | SIGNOR|EPSD|PSP|Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68431 | S11 | GPS6|SIGNOR|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P78371 | S143 | Sugiyama | CCT2 99D8.1 CCTB | PQTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84243 | S11 | GPS6|SIGNOR | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | __________MARtKQTARKstGGKAPRKQLATKAARKsAP |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q02818 | S193 | Sugiyama | NUCB1 NUC | HEEFKRyEMLKEHERRRyLEsLGEEQRKEAERKLEEQQRRH |
| Q04206 | S276 | PSP | RELA NFKB3 | PYADPsLQAPVRVsMQLRRPsDRELsEPMEFQYLPDTDDRH |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q05195 | S145 | GPS6 | MXD1 MAD | EQRHLKRQLEKLGIERIRMDsIGSTVSSERSDSDREEIDVD |
| Q06413 | S192 | GPS6|ELM|EPSD | MEF2C | LAHPSLQRNsMsPGVtHRPPsAGNtGGLMGGDLTSGAGTSA |
| Q07021 | S213 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | VGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDW |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09666 | S135 | Sugiyama | AHNAK PM227 | sGDDEEyQRIYttKIKPRLKsEDGVEGDLGEtQsRTITVTR |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13247 | S301 | Sugiyama | SRSF6 SFRS6 SRP55 | PKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKR |
| Q13428 | S85 | Sugiyama | TCOF1 | AEEDAALQAKKTRVsDPIstsEssEEEEEAEAETAKAtPRL |
| Q13442 | S57 | Sugiyama | PDAP1 HASPP28 | EEEQKEGGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGV |
| Q13442 | S60 | Sugiyama | PDAP1 HASPP28 | QKEGGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGL |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14697 | S169 | Sugiyama | GANAB G2AN KIAA0088 | IILTARPFRLDLLEDRSLLLsVNARGLLEFEHQRAPRVsQG |
| Q14697 | S187 | Sugiyama | GANAB G2AN KIAA0088 | LLsVNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRD |
| Q14697 | S190 | Sugiyama | GANAB G2AN KIAA0088 | VNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRDGDK |
| Q14790 | T263 | SIGNOR|EPSD|PSP | CASP8 MCH5 | NFAKAREKVPKLHSIRDRNGtHLDAGALTTtFEELHFEIKP |
| Q14934 | S281 | SIGNOR|EPSD|PSP | NFATC4 NFAT3 | RPAsPCGKRRYsssGtPssAsPALsRRGsLGEEGsEPPPPP |
| Q14934 | S285 | SIGNOR|EPSD|PSP | NFATC4 NFAT3 | PCGKRRYsssGtPssAsPALsRRGsLGEEGsEPPPPPPLPL |
| Q14934 | S289 | GPS6|SIGNOR|EPSD|PSP | NFATC4 NFAT3 | RRYsssGtPssAsPALsRRGsLGEEGsEPPPPPPLPLARDP |
| Q14934 | S334 | GPS6|EPSD | NFATC4 NFAT3 | PFDyVGAPPAESIPQKtRRtssEQAVALPRsEEPASCNGKL |
| Q14934 | S344 | SIGNOR|EPSD|PSP | NFATC4 NFAT3 | ESIPQKtRRtssEQAVALPRsEEPASCNGKLPLGAEESVAP |
| Q14934 | S676 | GPS6|SIGNOR|ELM|EPSD|PSP | NFATC4 NFAT3 | KRVSRPVQVYFYVSNGRRKRsPTQSFRFLPVICKEEPLPDS |
| Q15021 | S1330 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | sQRAPsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHP |
| Q15021 | T1331 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | QRAPsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHPN |
| Q15029 | S944 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | QPAPHLAREFMIKTRRRKGLsEDVsIsKFFDDPMLLELAKQ |
| Q15349 | S425 | Sugiyama | RPS6KA2 MAPKAPK1C RSK3 | HGNNIHFTDGYEIKEDIGVGsysVCKRCVHKAtDTEYAVKI |
| Q15349 | S427 | Sugiyama | RPS6KA2 MAPKAPK1C RSK3 | NNIHFTDGYEIKEDIGVGsysVCKRCVHKAtDTEYAVKIID |
| Q15428 | S153 | Sugiyama | SF3A2 SAP62 | LFQIDYPEIAEGIMPRHRFMsAyEQRIEPPDRRWQYLLMAA |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q15831 | S428 | iPTMNet|EPSD | STK11 LKB1 PJS | GRAPNPARKACSASSKIRRLsACKQQ_______________ |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16695 | S11 | iPTMNet|EPSD | H3-4 H3FT HIST3H3 | __________MARtKQTARKsTGGKAPRKQLATKVARKsAP |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q16821 | S46 | EPSD|PSP | PPP1R3A PP1G | CEDEEVTFQPGFSPQPSRRGsDsSEDIYLDTPSSGTRRVsF |
| Q16821 | S65 | EPSD|PSP | PPP1R3A PP1G | GsDsSEDIYLDTPSSGTRRVsFADSFGFNLVSVKEFDCWEL |
| Q32MZ4 | S766 | Sugiyama | LRRFIP1 GCF2 TRIP | sTERCEMSEHPSQTVRKALDsNsLENDDLSAPGREPGHFNP |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q4G0J3 | S258 | Sugiyama | LARP7 HDCMA18P | EENMDtsNtsIsKMKRsRPtsEGsDIEstEPQKQCSKKKKK |
| Q53EL6 | S76 | Sugiyama | PDCD4 H731 | NAKAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPK |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S258 | Sugiyama | HSP90AB2P HSP90BB | LAVRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQ |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T0N5 | S489 | Sugiyama | FNBP1L C1orf39 TOCA1 | EAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytDD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q71DI3 | S11 | GPS6 | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | __________MARtKQTARKsTGGKAPRKQLATKAARKsAP |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q7KZ85 | S125 | Sugiyama | SUPT6H KIAA0162 SPT6H | EENLGVKVKRGQKYRRVKKMsDDEDDDEEEYGKEEHEKEAI |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z4V5 | S369 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EKERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGR |
| Q7Z4V5 | S395 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | REDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKK |
| Q7Z5L9 | S15 | Sugiyama | IRF2BP2 | ______MAAAVAVAAASRRQsCyLCDLPRMPWAMIWDFTEP |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86W92 | S630 | Sugiyama | PPFIBP1 KIAA1230 | SEPEFKRGGTRATAGPRLGWsRDLGQsNsDLDMPFAKWTKE |
| Q8IX03 | S947 | SIGNOR|EPSD|PSP | WWC1 KIAA0869 KIBRA | sKtFsPGPQSQYVCRLNRsDsDsSTLSKKPPFVRNSLERRS |
| Q8IX03 | T929 | SIGNOR|EPSD|PSP | WWC1 KIAA0869 KIBRA | RVGtPsQGPFLRGSTIIRsKtFsPGPQSQYVCRLNRsDsDs |
| Q8N122 | S719 | GPS6 | RPTOR KIAA1303 RAPTOR | TTEGGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSL |
| Q8N122 | S721 | GPS6 | RPTOR KIAA1303 RAPTOR | EGGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSLQN |
| Q8N122 | S722 | GPS6 | RPTOR KIAA1303 RAPTOR | GGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSLQNL |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8TEW0 | S962 | Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92734 | S50 | Sugiyama | TFG | DITyDELVLMMQRVFRGKLLsNDEVTIKYKDEDGDLITIFD |
| Q92934 | S75 | GPS6|SIGNOR|ELM|EPSD|PSP | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92934 | S99 | EPSD|PSP | BAD BBC6 BCL2L8 | GtEDDEGMGEEPsPFRGRsRsAPPNLWAAQRYGRELRRMsD |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q96CV9 | S526 | Sugiyama | OPTN FIP2 GLC1E HIP7 HYPL NRP | FEDGGRQsLMEMQsRHGARtsDsDQQAyLVQRGAEDRDWRQ |
| Q96RU3 | Y500 | Sugiyama | FNBP1 FBP17 KIAA0554 | AEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREsPDG |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99683 | S83 | SIGNOR|EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | PGIGCPAATSSSSATRGRGSsVGGGSRRTTVAYVINEASQG |
| Q99683 | T1109 | SIGNOR|EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | TLIASLREFVRSTDRKIIATtLSKLKLELDFDSHGISQVQV |
| Q99683 | T1326 | SIGNOR|EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | TNTEDSELTDWLRVNGADEDtISRFLAEDYTLLDVLYYVTR |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99990 | S84 | SIGNOR|PSP | VGLL1 TDU | SEGVMLKNDDSMSPNQWRYSsPWTKPQPEVPVTNRAANCNL |
| Q9BQA1 | S185 | Sugiyama | WDR77 MEP50 WD45 HKMT1069 Nbla10071 | AHAAQVTCVAAsPHKDSVFLsCSEDNRILLWDTRCPKPASQ |
| Q9BQG0 | S1186 | Sugiyama | MYBBP1A P160 | sKKRKKKGFLPETKKRKKRKsEDGtPAEDGtPAATGGsQPP |
| Q9BSI4 | S295 | SIGNOR|EPSD|PSP | TINF2 TIN2 | TRGGHKERPTVMLFPFRNLGsPtQVISKPEsKEEHAIYTAD |
| Q9BSI4 | S330 | SIGNOR|EPSD|PSP | TINF2 TIN2 | AIYTADLAMGTRAASTGKSKsPCQTLGGRALKENPVDLPAT |
| Q9BVS4 | S483 | PSP | RIOK2 RIO2 | RPFRDEENVGAMNQYRTRtLsItssGsAVSCSTIPPELVKQ |
| Q9BWH6 | T1384 | Sugiyama | RPAP1 KIAA1403 | FELYSQLPPLRQHYLQRLTStVLQNGVSET___________ |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9C0C2 | S1616 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LSEAADsDAHLFQDSTEPRAsRVPssDEEVVEEPQsRRTRM |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H6Z4 | S126 | EPSD|PSP | RANBP3 | EDsDREDGNyCPPVKRERtssLtQFPPSQSEERSSGFRLKP |
| Q9H6Z4 | S57 | SIGNOR | RANBP3 | SGEEPRGEAEAPHHGTGHPEsAGEHALEPPAPAGASASTPP |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H788 | S317 | Sugiyama | SH2D4A PPP1R38 SH2A | SGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRAGY |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NTI5 | S1257 | Sugiyama | PDS5B APRIN AS3 KIAA0979 | LVQEQKPKGSQRSRKRGHtAsEsDEQQWPEEKRLKEDILEN |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NW13 | S200 | Sugiyama | RBM28 | KGRTVAVDWAVAKDKYKDTQsVsAIGEEKSHESKHQESVKK |
| Q9NY33 | S130 | Sugiyama | DPP3 | GDTKFVPNLPKEKLERVILGsEAAQQHPEEVRGLWQTCGEL |
| Q9NYV6 | S649 | GPS6|ELM|EPSD|PSP | RRN3 TIFIA | tHFRsPsssVGsPPVLyMQPsPL__________________ |
| Q9UBP6 | S27 | GPS6|Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UK32 | S436 | Sugiyama | RPS6KA6 RSK4 | NGNAAQFGEVYELKEDIGVGsysVCKRCIHATTNMEFAVKI |
| Q9UK32 | S438 | Sugiyama | RPS6KA6 RSK4 | NAAQFGEVYELKEDIGVGsysVCKRCIHATTNMEFAVKIID |
| Q9UL17 | S503 | EPSD|PSP | TBX21 TBET TBLYM | IRPESSDSGLGEGDSKRRRVsPyPsSGDSSSPAGAPSPFDK |
| Q9UL17 | S507 | EPSD|PSP | TBX21 TBET TBLYM | SSDSGLGEGDSKRRRVsPyPsSGDSSSPAGAPSPFDKEAEG |
| Q9ULD2 | T1204 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRLs |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y5K3 | S260 | GPS6 | PCYT1B CCTB | YRFQNQVDKMKEKVKNVEERsKEFVNRVEEKSHDLIQKWEE |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y6D5 | S277 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | RSDSGKVSTENGDAPRERGssLsGtDDGAQEVVKDILEDVV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin modifying enzymes | R-HSA-3247509 | 3.952156e-09 | 8.403 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.450220e-08 | 7.839 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.525979e-06 | 5.598 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.263573e-06 | 5.486 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.479034e-06 | 5.459 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.118136e-06 | 5.385 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.086214e-06 | 5.150 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.351961e-06 | 5.134 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.936338e-06 | 5.100 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.738115e-06 | 5.059 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 9.616203e-06 | 5.017 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.249355e-05 | 4.903 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.214756e-05 | 4.916 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.658716e-05 | 4.780 | 1 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.213591e-05 | 4.655 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.699297e-05 | 4.569 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.032353e-05 | 4.518 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.188852e-05 | 4.496 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.802551e-05 | 4.420 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.089760e-05 | 4.388 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.283477e-05 | 4.368 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.682034e-05 | 4.245 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.854381e-05 | 4.233 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.144971e-05 | 4.089 | 1 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.858462e-05 | 4.053 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.795564e-05 | 4.056 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.574974e-05 | 4.067 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.084652e-05 | 4.042 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.061805e-04 | 3.974 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.647823e-04 | 3.577 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.783696e-04 | 3.555 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.211487e-04 | 3.493 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.357822e-04 | 3.474 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.401978e-04 | 3.468 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.603662e-04 | 3.443 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.663458e-04 | 3.436 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.687405e-04 | 3.433 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.901975e-04 | 3.409 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.450582e-04 | 3.352 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.450582e-04 | 3.352 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.657757e-04 | 3.332 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.019807e-04 | 3.299 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.987823e-04 | 3.302 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.939134e-04 | 3.306 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.111297e-04 | 3.291 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.293000e-04 | 3.276 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.610474e-04 | 3.251 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.481845e-04 | 3.261 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.425886e-04 | 3.192 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.501778e-04 | 3.125 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.392753e-04 | 3.076 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.822751e-04 | 3.054 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.205230e-04 | 3.036 | 1 | 1 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.059502e-03 | 2.975 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.098023e-03 | 2.959 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.178135e-03 | 2.929 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.496504e-03 | 2.825 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.507396e-03 | 2.822 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.690936e-03 | 2.772 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.730251e-03 | 2.762 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.730251e-03 | 2.762 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.750330e-03 | 2.757 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.056443e-03 | 2.687 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.135245e-03 | 2.671 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.135245e-03 | 2.671 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.052189e-03 | 2.688 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.294292e-03 | 2.639 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.461417e-03 | 2.609 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.355751e-03 | 2.628 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.355627e-03 | 2.628 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.407907e-03 | 2.618 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.733772e-03 | 2.563 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.643507e-03 | 2.578 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.610003e-03 | 2.583 | 1 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.685844e-03 | 2.571 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.943489e-03 | 2.531 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.334636e-03 | 2.477 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.447727e-03 | 2.462 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.516623e-03 | 2.454 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.759160e-03 | 2.425 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.759160e-03 | 2.425 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.835661e-03 | 2.416 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.177110e-03 | 2.379 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.007656e-03 | 2.397 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.177110e-03 | 2.379 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.541058e-03 | 2.343 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.550992e-03 | 2.342 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.924225e-03 | 2.308 | 1 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.264184e-03 | 2.279 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.264184e-03 | 2.279 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.478176e-03 | 2.261 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.530361e-03 | 2.257 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.061211e-03 | 2.217 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.797681e-03 | 2.237 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.797681e-03 | 2.237 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.148101e-03 | 2.211 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.187968e-03 | 2.208 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.246921e-03 | 2.204 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.814545e-03 | 2.167 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.630613e-03 | 2.178 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.777603e-03 | 2.169 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.486420e-03 | 2.188 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.052928e-03 | 2.152 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.635719e-03 | 2.117 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.884472e-03 | 2.103 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.148326e-03 | 2.089 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.872175e-03 | 2.052 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.178922e-03 | 2.037 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.285149e-03 | 2.032 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.460044e-03 | 2.024 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.032540e-02 | 1.986 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.007716e-02 | 1.997 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.032854e-02 | 1.986 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.032854e-02 | 1.986 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.134022e-02 | 1.945 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.134022e-02 | 1.945 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.127031e-02 | 1.948 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.127031e-02 | 1.948 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.089121e-02 | 1.963 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.064191e-02 | 1.973 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.092650e-02 | 1.962 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.069369e-02 | 1.971 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.052250e-02 | 1.978 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.165727e-02 | 1.933 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.165727e-02 | 1.933 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.245906e-02 | 1.905 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.431553e-02 | 1.844 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.377537e-02 | 1.861 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.333122e-02 | 1.875 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.390322e-02 | 1.857 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.377537e-02 | 1.861 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.393845e-02 | 1.856 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.427741e-02 | 1.845 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.566248e-02 | 1.805 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.566248e-02 | 1.805 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.673873e-02 | 1.776 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.719810e-02 | 1.765 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.822617e-02 | 1.739 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.828361e-02 | 1.738 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.841725e-02 | 1.735 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.852917e-02 | 1.732 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.018542e-02 | 1.695 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.959394e-02 | 1.708 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.113191e-02 | 1.675 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.121366e-02 | 1.673 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.082105e-02 | 1.681 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.253827e-02 | 1.647 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.264385e-02 | 1.645 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.295578e-02 | 1.639 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.315714e-02 | 1.635 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.319317e-02 | 1.635 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.368972e-02 | 1.625 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.435213e-02 | 1.613 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.538391e-02 | 1.595 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.538391e-02 | 1.595 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.866698e-02 | 1.543 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.871074e-02 | 1.542 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.628288e-02 | 1.580 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.599696e-02 | 1.585 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.717359e-02 | 1.566 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.772740e-02 | 1.557 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.871074e-02 | 1.542 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.838884e-02 | 1.547 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.905494e-02 | 1.537 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.008177e-02 | 1.522 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.054635e-02 | 1.515 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.057750e-02 | 1.515 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.203806e-02 | 1.494 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.211845e-02 | 1.493 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.211845e-02 | 1.493 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.211845e-02 | 1.493 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.211845e-02 | 1.493 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.211845e-02 | 1.493 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.220703e-02 | 1.492 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.257377e-02 | 1.487 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.847575e-02 | 1.415 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.847575e-02 | 1.415 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.847575e-02 | 1.415 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.787018e-02 | 1.422 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.787018e-02 | 1.422 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.847575e-02 | 1.415 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.847575e-02 | 1.415 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.847575e-02 | 1.415 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.637990e-02 | 1.439 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.889935e-02 | 1.410 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.138132e-02 | 1.383 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.191478e-02 | 1.378 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.371469e-02 | 1.359 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.371469e-02 | 1.359 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 4.661900e-02 | 1.331 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.698952e-02 | 1.328 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.698952e-02 | 1.328 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.698952e-02 | 1.328 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.997554e-02 | 1.301 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.997554e-02 | 1.301 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.380468e-02 | 1.358 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.841553e-02 | 1.315 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.884305e-02 | 1.311 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.884305e-02 | 1.311 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.884305e-02 | 1.311 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.511468e-02 | 1.346 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.698952e-02 | 1.328 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.884305e-02 | 1.311 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.997554e-02 | 1.301 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.807342e-02 | 1.318 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.807342e-02 | 1.318 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.586498e-02 | 1.339 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.380468e-02 | 1.358 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.650991e-02 | 1.332 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.586498e-02 | 1.339 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.625192e-02 | 1.335 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.035763e-02 | 1.298 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.180644e-02 | 1.286 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.190436e-02 | 1.285 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.190436e-02 | 1.285 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.319975e-02 | 1.274 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.495604e-02 | 1.260 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.717864e-02 | 1.243 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.756620e-02 | 1.240 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.778687e-02 | 1.238 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.778687e-02 | 1.238 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.888596e-02 | 1.230 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.888596e-02 | 1.230 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.888596e-02 | 1.230 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.134445e-02 | 1.212 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.315492e-02 | 1.200 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.436076e-02 | 1.191 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.465764e-02 | 1.189 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.465764e-02 | 1.189 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.465764e-02 | 1.189 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.465764e-02 | 1.189 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.468612e-02 | 1.189 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 7.702248e-02 | 1.113 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 7.702248e-02 | 1.113 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 7.702248e-02 | 1.113 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.856117e-02 | 1.164 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.716159e-02 | 1.173 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.748931e-02 | 1.171 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.716159e-02 | 1.173 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.994996e-02 | 1.155 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.760745e-02 | 1.170 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.672796e-02 | 1.176 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.952183e-02 | 1.158 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.797141e-02 | 1.108 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.105795e-02 | 1.091 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.105795e-02 | 1.091 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.116014e-02 | 1.091 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.162182e-02 | 1.088 | 1 | 1 |
| Cardiogenesis | R-HSA-9733709 | 8.162182e-02 | 1.088 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.162182e-02 | 1.088 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.162182e-02 | 1.088 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.452442e-02 | 1.073 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.452442e-02 | 1.073 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 8.491048e-02 | 1.071 | 1 | 1 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 8.491048e-02 | 1.071 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.491048e-02 | 1.071 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.610078e-02 | 1.065 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.684042e-02 | 1.061 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.684042e-02 | 1.061 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.074886e-01 | 0.969 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.074886e-01 | 0.969 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.074886e-01 | 0.969 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.074886e-01 | 0.969 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 9.435595e-02 | 1.025 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.150495e-02 | 1.039 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.327341e-02 | 1.030 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.327341e-02 | 1.030 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.327341e-02 | 1.030 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.075951e-01 | 0.968 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.974875e-02 | 1.001 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.979397e-02 | 1.047 | 1 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.074886e-01 | 0.969 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.843451e-02 | 1.007 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.039764e-01 | 0.983 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.150495e-02 | 1.039 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.470320e-02 | 1.024 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.429424e-02 | 1.026 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.076487e-01 | 0.968 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.076487e-01 | 0.968 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.076487e-01 | 0.968 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.076487e-01 | 0.968 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.076487e-01 | 0.968 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.076487e-01 | 0.968 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.076487e-01 | 0.968 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.094371e-01 | 0.961 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.094725e-01 | 0.961 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.094725e-01 | 0.961 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.101177e-01 | 0.958 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.120160e-01 | 0.951 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.122173e-01 | 0.950 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.122931e-01 | 0.950 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.122931e-01 | 0.950 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.152627e-01 | 0.938 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.153898e-01 | 0.938 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.173135e-01 | 0.931 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.198728e-01 | 0.921 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.211307e-01 | 0.917 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.037147e-01 | 0.691 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.037147e-01 | 0.691 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.037147e-01 | 0.691 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.037147e-01 | 0.691 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.037147e-01 | 0.691 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.037147e-01 | 0.691 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.037147e-01 | 0.691 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.037147e-01 | 0.691 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.500184e-01 | 0.824 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.500184e-01 | 0.824 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.500184e-01 | 0.824 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.500184e-01 | 0.824 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.894438e-01 | 0.538 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.894438e-01 | 0.538 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.894438e-01 | 0.538 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.894438e-01 | 0.538 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.894438e-01 | 0.538 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.894438e-01 | 0.538 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.894438e-01 | 0.538 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.894438e-01 | 0.538 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.894438e-01 | 0.538 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.894438e-01 | 0.538 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.902012e-01 | 0.721 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 1.902012e-01 | 0.721 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.902012e-01 | 0.721 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.321046e-01 | 0.879 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.584577e-01 | 0.800 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.584577e-01 | 0.800 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.315862e-01 | 0.635 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.315862e-01 | 0.635 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.315862e-01 | 0.635 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.315862e-01 | 0.635 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.315862e-01 | 0.635 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.315862e-01 | 0.635 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.659477e-01 | 0.437 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.659477e-01 | 0.437 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.659477e-01 | 0.437 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.659477e-01 | 0.437 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.659477e-01 | 0.437 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.659477e-01 | 0.437 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.659477e-01 | 0.437 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.659477e-01 | 0.437 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.659477e-01 | 0.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.659477e-01 | 0.437 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.659477e-01 | 0.437 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.862454e-01 | 0.730 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.862454e-01 | 0.730 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 1.519213e-01 | 0.818 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.734494e-01 | 0.563 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.734494e-01 | 0.563 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.252093e-01 | 0.902 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.151719e-01 | 0.667 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.151719e-01 | 0.667 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.151719e-01 | 0.667 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.151719e-01 | 0.667 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.151719e-01 | 0.667 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.735091e-01 | 0.761 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.735091e-01 | 0.761 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.735091e-01 | 0.761 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.419599e-01 | 0.848 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.960716e-01 | 0.708 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.960716e-01 | 0.708 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.960716e-01 | 0.708 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.449539e-01 | 0.611 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.449539e-01 | 0.611 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.449539e-01 | 0.611 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.152086e-01 | 0.501 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.152086e-01 | 0.501 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.152086e-01 | 0.501 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.152086e-01 | 0.501 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.342186e-01 | 0.362 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.342186e-01 | 0.362 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.342186e-01 | 0.362 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.342186e-01 | 0.362 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.781185e-01 | 0.749 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.194671e-01 | 0.659 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.339046e-01 | 0.873 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.753256e-01 | 0.560 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.753256e-01 | 0.560 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.753256e-01 | 0.560 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.753256e-01 | 0.560 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.753256e-01 | 0.560 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.753256e-01 | 0.560 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.225910e-01 | 0.912 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.225910e-01 | 0.912 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.973727e-01 | 0.705 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.973727e-01 | 0.705 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.473126e-01 | 0.832 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.564012e-01 | 0.448 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.564012e-01 | 0.448 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.564012e-01 | 0.448 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.173006e-01 | 0.663 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.060411e-01 | 0.514 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.060411e-01 | 0.514 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.060411e-01 | 0.514 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.681905e-01 | 0.572 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.125467e-01 | 0.673 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.588349e-01 | 0.587 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.932413e-01 | 0.533 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.966654e-01 | 0.402 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.951421e-01 | 0.305 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.951421e-01 | 0.305 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.951421e-01 | 0.305 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.951421e-01 | 0.305 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.951421e-01 | 0.305 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.951421e-01 | 0.305 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.447664e-01 | 0.839 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.489979e-01 | 0.604 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.802680e-01 | 0.552 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.802680e-01 | 0.552 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.406784e-01 | 0.852 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.185748e-01 | 0.497 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.676292e-01 | 0.435 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.676292e-01 | 0.435 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.676292e-01 | 0.435 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.590787e-01 | 0.798 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.923447e-01 | 0.716 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.923447e-01 | 0.716 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.440661e-01 | 0.463 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.357239e-01 | 0.361 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.357239e-01 | 0.361 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.357239e-01 | 0.361 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.240383e-01 | 0.489 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.695978e-01 | 0.432 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.462098e-01 | 0.461 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.462098e-01 | 0.461 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.462098e-01 | 0.461 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.262031e-01 | 0.487 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.684667e-01 | 0.434 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.684667e-01 | 0.434 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.684667e-01 | 0.434 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.950608e-01 | 0.403 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 4.281955e-01 | 0.368 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.733695e-01 | 0.325 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.495085e-01 | 0.260 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.495085e-01 | 0.260 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.495085e-01 | 0.260 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.495085e-01 | 0.260 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.495085e-01 | 0.260 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.495085e-01 | 0.260 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.495085e-01 | 0.260 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.495085e-01 | 0.260 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.446957e-01 | 0.463 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.797699e-01 | 0.553 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.203544e-01 | 0.376 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.577163e-01 | 0.339 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.595116e-01 | 0.444 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.094538e-01 | 0.293 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.094538e-01 | 0.293 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.094538e-01 | 0.293 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.672329e-01 | 0.435 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.934342e-01 | 0.405 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.865683e-01 | 0.313 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.865683e-01 | 0.313 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.178415e-01 | 0.379 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.424782e-01 | 0.465 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.424782e-01 | 0.465 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.700755e-01 | 0.328 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.310784e-01 | 0.480 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.785602e-01 | 0.320 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.785602e-01 | 0.320 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.785602e-01 | 0.320 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.943463e-01 | 0.306 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.146553e-01 | 0.288 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.146553e-01 | 0.288 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.146553e-01 | 0.288 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.146553e-01 | 0.288 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.438766e-01 | 0.264 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.438766e-01 | 0.264 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.438766e-01 | 0.264 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.438766e-01 | 0.264 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.980232e-01 | 0.223 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.980232e-01 | 0.223 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.980232e-01 | 0.223 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.980232e-01 | 0.223 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.980232e-01 | 0.223 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.980232e-01 | 0.223 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.980232e-01 | 0.223 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.980232e-01 | 0.223 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.264211e-01 | 0.370 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.181342e-01 | 0.286 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.181342e-01 | 0.286 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.418983e-01 | 0.266 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.418983e-01 | 0.266 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.418983e-01 | 0.266 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.418983e-01 | 0.266 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.418983e-01 | 0.266 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.807516e-01 | 0.318 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.413823e-01 | 0.266 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.765772e-01 | 0.239 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.765772e-01 | 0.239 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.596836e-01 | 0.252 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.860729e-01 | 0.232 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.936156e-01 | 0.226 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.075274e-01 | 0.216 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.075274e-01 | 0.216 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.075274e-01 | 0.216 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.075274e-01 | 0.216 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.960794e-01 | 0.225 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.086587e-01 | 0.216 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.086587e-01 | 0.216 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.071667e-01 | 0.684 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.814511e-01 | 0.235 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.225910e-01 | 0.912 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.613261e-01 | 0.792 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.569137e-01 | 0.340 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.929225e-01 | 0.533 | 1 | 1 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.228494e-01 | 0.282 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.443352e-01 | 0.264 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.443352e-01 | 0.264 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.445136e-01 | 0.840 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.305434e-01 | 0.637 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.458121e-01 | 0.836 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.378169e-01 | 0.624 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.415284e-01 | 0.266 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.418983e-01 | 0.266 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.220491e-01 | 0.375 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.252093e-01 | 0.902 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.523480e-01 | 0.598 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.523480e-01 | 0.598 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.584577e-01 | 0.800 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.194671e-01 | 0.659 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.753256e-01 | 0.560 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.473126e-01 | 0.832 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.660678e-01 | 0.780 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.608079e-01 | 0.584 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.860729e-01 | 0.232 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.523480e-01 | 0.598 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.700755e-01 | 0.328 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.272951e-01 | 0.369 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.413823e-01 | 0.266 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.252093e-01 | 0.902 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.440661e-01 | 0.463 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.495085e-01 | 0.260 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.247694e-01 | 0.648 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.418983e-01 | 0.266 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.195262e-01 | 0.377 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.195262e-01 | 0.377 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.314466e-01 | 0.881 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.953538e-01 | 0.225 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.074581e-01 | 0.683 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.814511e-01 | 0.235 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.112407e-01 | 0.507 | 1 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.802680e-01 | 0.552 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.902012e-01 | 0.721 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.315862e-01 | 0.635 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.862454e-01 | 0.730 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.152086e-01 | 0.501 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.564012e-01 | 0.448 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.173006e-01 | 0.663 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 3.060411e-01 | 0.514 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.966654e-01 | 0.402 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.357239e-01 | 0.361 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.262031e-01 | 0.487 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.086321e-01 | 0.511 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.577163e-01 | 0.339 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.577163e-01 | 0.339 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.423150e-01 | 0.354 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.446957e-01 | 0.463 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.020305e-01 | 0.520 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.865683e-01 | 0.313 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.259165e-01 | 0.487 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.999089e-01 | 0.301 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.317178e-01 | 0.880 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.434806e-01 | 0.265 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.596211e-01 | 0.797 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.785602e-01 | 0.320 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.500184e-01 | 0.824 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.321046e-01 | 0.879 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.321046e-01 | 0.879 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.584577e-01 | 0.800 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.315862e-01 | 0.635 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.753256e-01 | 0.560 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.564012e-01 | 0.448 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.951421e-01 | 0.305 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.684667e-01 | 0.434 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.495085e-01 | 0.260 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.627633e-01 | 0.580 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.865683e-01 | 0.313 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.972168e-01 | 0.401 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.569137e-01 | 0.340 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.438766e-01 | 0.264 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.438766e-01 | 0.264 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.001512e-01 | 0.301 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.273861e-01 | 0.278 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.300412e-01 | 0.886 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.405148e-01 | 0.852 | 1 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.870427e-01 | 0.542 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.923447e-01 | 0.716 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.994827e-01 | 0.700 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.618772e-01 | 0.791 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.862454e-01 | 0.730 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.613261e-01 | 0.792 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 3.684667e-01 | 0.434 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.700755e-01 | 0.328 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.438766e-01 | 0.264 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.999089e-01 | 0.301 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.828209e-01 | 0.316 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.245091e-01 | 0.649 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.850106e-01 | 0.314 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.433434e-01 | 0.844 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.764487e-01 | 0.424 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.936156e-01 | 0.226 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.812783e-01 | 0.318 | 1 | 0 |
| TNF signaling | R-HSA-75893 | 4.443607e-01 | 0.352 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.382349e-01 | 0.859 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.960716e-01 | 0.708 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.938074e-01 | 0.713 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.565709e-01 | 0.805 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.584577e-01 | 0.800 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.315862e-01 | 0.635 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.314466e-01 | 0.881 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.519213e-01 | 0.818 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.435535e-01 | 0.613 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.870427e-01 | 0.542 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.981213e-01 | 0.400 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.981213e-01 | 0.400 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.733695e-01 | 0.325 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.495085e-01 | 0.260 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.094538e-01 | 0.293 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.879145e-01 | 0.726 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.717821e-01 | 0.430 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.717821e-01 | 0.430 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.717821e-01 | 0.430 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.717821e-01 | 0.430 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.569137e-01 | 0.340 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.042887e-01 | 0.297 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.452294e-01 | 0.263 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.088474e-01 | 0.215 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.462649e-01 | 0.835 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.227547e-01 | 0.652 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.420154e-01 | 0.266 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.420154e-01 | 0.266 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.749848e-01 | 0.240 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.588349e-01 | 0.587 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.346902e-01 | 0.475 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.767379e-01 | 0.558 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.012947e-01 | 0.300 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.733695e-01 | 0.325 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.458064e-01 | 0.351 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.227547e-01 | 0.652 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.094538e-01 | 0.293 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.876718e-01 | 0.412 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.938214e-01 | 0.226 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.629181e-01 | 0.440 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.608079e-01 | 0.584 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.500184e-01 | 0.824 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.315862e-01 | 0.635 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.613261e-01 | 0.792 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.357239e-01 | 0.361 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.695978e-01 | 0.432 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.091089e-01 | 0.510 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.060152e-01 | 0.391 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.943463e-01 | 0.306 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.980232e-01 | 0.223 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.740276e-01 | 0.241 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.277926e-01 | 0.893 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.048849e-01 | 0.218 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.119416e-01 | 0.506 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.865683e-01 | 0.313 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.130901e-01 | 0.384 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.903579e-01 | 0.229 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.449539e-01 | 0.611 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.086321e-01 | 0.511 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.460541e-01 | 0.461 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.438766e-01 | 0.264 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.413823e-01 | 0.266 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.640422e-01 | 0.249 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.319353e-01 | 0.880 | 1 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.460541e-01 | 0.461 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.175926e-01 | 0.498 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.225233e-01 | 0.282 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.152086e-01 | 0.501 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.675744e-01 | 0.776 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.495085e-01 | 0.260 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.446957e-01 | 0.463 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.907341e-01 | 0.408 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.094538e-01 | 0.293 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.421072e-01 | 0.466 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.203544e-01 | 0.376 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.422073e-01 | 0.616 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.453869e-01 | 0.351 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.281854e-01 | 0.277 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.068087e-01 | 0.684 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.628086e-01 | 0.440 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.748690e-01 | 0.426 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.421178e-01 | 0.847 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.046567e-01 | 0.393 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.717808e-01 | 0.243 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.245815e-01 | 0.372 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.962971e-01 | 0.304 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.495285e-01 | 0.603 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.268157e-01 | 0.897 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.894438e-01 | 0.538 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.902012e-01 | 0.721 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.659477e-01 | 0.437 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.151719e-01 | 0.667 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.449539e-01 | 0.611 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.449539e-01 | 0.611 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.152086e-01 | 0.501 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.342186e-01 | 0.362 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.342186e-01 | 0.362 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.194671e-01 | 0.659 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.753256e-01 | 0.560 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.060411e-01 | 0.514 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.966654e-01 | 0.402 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.698846e-01 | 0.770 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.357239e-01 | 0.361 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.981213e-01 | 0.400 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.695978e-01 | 0.432 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.733695e-01 | 0.325 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.495085e-01 | 0.260 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.495085e-01 | 0.260 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.017954e-01 | 0.520 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.559533e-01 | 0.449 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.453869e-01 | 0.351 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.651473e-01 | 0.577 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.865683e-01 | 0.313 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.865683e-01 | 0.313 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.980232e-01 | 0.223 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.980232e-01 | 0.223 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.980232e-01 | 0.223 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.980232e-01 | 0.223 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.980232e-01 | 0.223 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 5.980232e-01 | 0.223 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.999089e-01 | 0.301 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.418983e-01 | 0.266 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.006959e-01 | 0.221 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.727715e-01 | 0.242 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.582413e-01 | 0.446 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.756230e-01 | 0.755 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.828209e-01 | 0.316 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.227547e-01 | 0.652 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.037956e-01 | 0.691 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.458064e-01 | 0.351 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.943463e-01 | 0.306 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.075274e-01 | 0.216 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.861556e-01 | 0.730 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.656526e-01 | 0.437 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.809510e-01 | 0.742 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.197801e-01 | 0.377 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.146553e-01 | 0.288 | 1 | 1 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.458064e-01 | 0.351 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.684667e-01 | 0.434 | 1 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.313352e-01 | 0.275 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.608079e-01 | 0.584 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.589839e-01 | 0.799 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.589839e-01 | 0.799 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.784300e-01 | 0.238 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.474983e-01 | 0.831 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.769674e-01 | 0.424 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.731871e-01 | 0.428 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.973727e-01 | 0.705 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.281955e-01 | 0.368 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.233013e-01 | 0.281 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.682345e-01 | 0.245 | 1 | 1 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.927805e-01 | 0.227 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.826117e-01 | 0.417 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.443930e-01 | 0.463 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.865683e-01 | 0.313 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.765772e-01 | 0.239 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.446217e-01 | 0.840 | 1 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.346902e-01 | 0.475 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.341239e-01 | 0.362 | 1 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.584577e-01 | 0.800 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.152086e-01 | 0.501 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.060411e-01 | 0.514 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.060411e-01 | 0.514 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.966654e-01 | 0.402 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.203544e-01 | 0.376 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.980232e-01 | 0.223 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.980232e-01 | 0.223 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.980232e-01 | 0.223 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.480089e-01 | 0.261 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.462098e-01 | 0.461 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.345306e-01 | 0.476 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.932413e-01 | 0.533 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.717821e-01 | 0.430 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.382367e-01 | 0.471 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.368762e-01 | 0.473 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.966654e-01 | 0.402 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.802680e-01 | 0.552 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.499862e-01 | 0.456 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.681905e-01 | 0.572 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.035480e-01 | 0.298 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.146847e-01 | 0.288 | 1 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.209125e-01 | 0.283 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.180958e-01 | 0.497 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.894438e-01 | 0.538 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.659477e-01 | 0.437 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.862454e-01 | 0.730 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.151719e-01 | 0.667 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.735091e-01 | 0.761 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.342186e-01 | 0.362 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.194671e-01 | 0.659 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.781583e-01 | 0.749 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.681905e-01 | 0.572 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.966654e-01 | 0.402 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.951421e-01 | 0.305 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.357239e-01 | 0.361 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.733695e-01 | 0.325 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.495085e-01 | 0.260 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.980232e-01 | 0.223 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.420154e-01 | 0.266 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.667901e-01 | 0.331 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.543317e-01 | 0.451 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.086321e-01 | 0.511 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.054940e-01 | 0.392 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.418983e-01 | 0.266 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.350217e-01 | 0.361 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.862454e-01 | 0.730 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.734494e-01 | 0.563 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.227547e-01 | 0.652 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.870427e-01 | 0.542 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.867320e-01 | 0.543 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.672329e-01 | 0.435 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.152591e-01 | 0.667 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.847304e-01 | 0.233 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.848317e-01 | 0.233 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.584538e-01 | 0.339 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.867320e-01 | 0.543 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.254355e-01 | 0.279 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.784300e-01 | 0.238 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.860729e-01 | 0.232 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.125908e-01 | 0.384 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.091089e-01 | 0.510 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.406272e-01 | 0.468 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.902012e-01 | 0.721 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.315862e-01 | 0.635 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.152086e-01 | 0.501 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.152086e-01 | 0.501 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.564012e-01 | 0.448 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.951421e-01 | 0.305 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.091089e-01 | 0.510 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.980232e-01 | 0.223 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.980232e-01 | 0.223 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.765772e-01 | 0.239 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.308935e-01 | 0.275 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.450778e-01 | 0.838 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.149677e-01 | 0.668 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.981213e-01 | 0.400 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.802680e-01 | 0.552 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.020305e-01 | 0.520 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.418983e-01 | 0.266 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.368762e-01 | 0.473 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.640519e-01 | 0.439 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.329946e-01 | 0.633 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.210875e-01 | 0.283 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.146553e-01 | 0.288 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.617190e-01 | 0.250 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.966654e-01 | 0.402 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.676292e-01 | 0.435 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.495085e-01 | 0.260 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.980232e-01 | 0.223 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.426035e-01 | 0.354 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.195262e-01 | 0.377 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.681905e-01 | 0.572 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.454162e-01 | 0.351 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.438766e-01 | 0.264 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.682345e-01 | 0.245 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.442959e-01 | 0.612 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.814511e-01 | 0.235 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.839983e-01 | 0.234 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.513079e-01 | 0.346 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.357239e-01 | 0.361 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.305434e-01 | 0.637 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.133276e-01 | 0.212 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.161773e-01 | 0.210 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.168731e-01 | 0.210 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.180065e-01 | 0.209 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.180065e-01 | 0.209 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.180065e-01 | 0.209 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.187111e-01 | 0.209 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.187111e-01 | 0.209 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.194293e-01 | 0.208 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.194293e-01 | 0.208 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.194293e-01 | 0.208 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.194293e-01 | 0.208 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.245711e-01 | 0.204 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.281190e-01 | 0.202 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.281190e-01 | 0.202 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.301564e-01 | 0.201 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.301564e-01 | 0.201 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.318313e-01 | 0.199 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.318313e-01 | 0.199 | 1 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.347741e-01 | 0.197 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.367250e-01 | 0.196 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.367250e-01 | 0.196 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.367250e-01 | 0.196 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.367250e-01 | 0.196 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.367250e-01 | 0.196 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.367250e-01 | 0.196 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.367250e-01 | 0.196 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.367250e-01 | 0.196 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.367250e-01 | 0.196 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.367250e-01 | 0.196 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.367250e-01 | 0.196 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.367250e-01 | 0.196 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.367250e-01 | 0.196 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.367837e-01 | 0.196 | 1 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.399370e-01 | 0.194 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.402120e-01 | 0.194 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.413158e-01 | 0.193 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.413158e-01 | 0.193 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.413158e-01 | 0.193 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.413158e-01 | 0.193 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.413158e-01 | 0.193 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.413158e-01 | 0.193 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.413158e-01 | 0.193 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.413158e-01 | 0.193 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.413158e-01 | 0.193 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.413158e-01 | 0.193 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.413158e-01 | 0.193 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.413837e-01 | 0.193 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.413837e-01 | 0.193 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.423092e-01 | 0.192 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.465500e-01 | 0.189 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.480870e-01 | 0.188 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.480870e-01 | 0.188 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.480870e-01 | 0.188 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.480870e-01 | 0.188 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.497326e-01 | 0.187 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.532776e-01 | 0.185 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.551245e-01 | 0.184 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.552844e-01 | 0.184 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.574124e-01 | 0.182 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.576468e-01 | 0.182 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.628405e-01 | 0.179 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.641883e-01 | 0.178 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.641883e-01 | 0.178 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.641883e-01 | 0.178 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.641883e-01 | 0.178 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.641883e-01 | 0.178 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.641883e-01 | 0.178 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 6.641883e-01 | 0.178 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.670888e-01 | 0.176 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.673301e-01 | 0.176 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.673301e-01 | 0.176 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.703272e-01 | 0.174 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.723770e-01 | 0.172 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.763805e-01 | 0.170 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.775568e-01 | 0.169 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.784060e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.798192e-01 | 0.168 | 1 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.799481e-01 | 0.168 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.799481e-01 | 0.168 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.799481e-01 | 0.168 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.799481e-01 | 0.168 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.799481e-01 | 0.168 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.799481e-01 | 0.168 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.799481e-01 | 0.168 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.799481e-01 | 0.168 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.799481e-01 | 0.168 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.799481e-01 | 0.168 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.799481e-01 | 0.168 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.799481e-01 | 0.168 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.799481e-01 | 0.168 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.799481e-01 | 0.168 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.799481e-01 | 0.168 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.837749e-01 | 0.165 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.850531e-01 | 0.164 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.850531e-01 | 0.164 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.850531e-01 | 0.164 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.850531e-01 | 0.164 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.858387e-01 | 0.164 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.858387e-01 | 0.164 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.888995e-01 | 0.162 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.899523e-01 | 0.161 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.899523e-01 | 0.161 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.899523e-01 | 0.161 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.899523e-01 | 0.161 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.899523e-01 | 0.161 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.899523e-01 | 0.161 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.899523e-01 | 0.161 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.899523e-01 | 0.161 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.899523e-01 | 0.161 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.930395e-01 | 0.159 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.976053e-01 | 0.156 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.018362e-01 | 0.154 | 1 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.048457e-01 | 0.152 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.053449e-01 | 0.152 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.110344e-01 | 0.148 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.110344e-01 | 0.148 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.122802e-01 | 0.147 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.140643e-01 | 0.146 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.140643e-01 | 0.146 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.140643e-01 | 0.146 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.140643e-01 | 0.146 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.140643e-01 | 0.146 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.140643e-01 | 0.146 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.144214e-01 | 0.146 | 1 | 1 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.144214e-01 | 0.146 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.144214e-01 | 0.146 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.144214e-01 | 0.146 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.144214e-01 | 0.146 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.144214e-01 | 0.146 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.144214e-01 | 0.146 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.144214e-01 | 0.146 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.144214e-01 | 0.146 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.144214e-01 | 0.146 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.144214e-01 | 0.146 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.144214e-01 | 0.146 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.144214e-01 | 0.146 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.144214e-01 | 0.146 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.171612e-01 | 0.144 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.202124e-01 | 0.143 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.202124e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.202124e-01 | 0.143 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.202124e-01 | 0.143 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.206385e-01 | 0.142 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.206385e-01 | 0.142 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.233413e-01 | 0.141 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.246199e-01 | 0.140 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.246199e-01 | 0.140 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.246199e-01 | 0.140 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.246199e-01 | 0.140 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.246199e-01 | 0.140 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.266971e-01 | 0.139 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.266971e-01 | 0.139 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.317355e-01 | 0.136 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.349991e-01 | 0.134 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.349991e-01 | 0.134 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.349991e-01 | 0.134 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.352135e-01 | 0.134 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.365813e-01 | 0.133 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.365813e-01 | 0.133 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.365813e-01 | 0.133 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.365813e-01 | 0.133 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.428940e-01 | 0.129 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.428940e-01 | 0.129 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.428940e-01 | 0.129 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.451834e-01 | 0.128 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.451834e-01 | 0.128 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.451834e-01 | 0.128 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.451834e-01 | 0.128 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.451834e-01 | 0.128 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.451834e-01 | 0.128 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.451834e-01 | 0.128 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.451834e-01 | 0.128 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.451834e-01 | 0.128 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.451834e-01 | 0.128 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.451834e-01 | 0.128 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.451834e-01 | 0.128 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.451834e-01 | 0.128 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.451834e-01 | 0.128 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.451834e-01 | 0.128 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.454886e-01 | 0.128 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.488835e-01 | 0.126 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.492077e-01 | 0.125 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.523906e-01 | 0.124 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.564813e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.575671e-01 | 0.121 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.575671e-01 | 0.121 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.575671e-01 | 0.121 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.601884e-01 | 0.119 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.601884e-01 | 0.119 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.601884e-01 | 0.119 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.628597e-01 | 0.118 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.647575e-01 | 0.116 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 7.721610e-01 | 0.112 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.726334e-01 | 0.112 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.726334e-01 | 0.112 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.726334e-01 | 0.112 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.726334e-01 | 0.112 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.726334e-01 | 0.112 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.726334e-01 | 0.112 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.726334e-01 | 0.112 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.726334e-01 | 0.112 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.726334e-01 | 0.112 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.726334e-01 | 0.112 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.726334e-01 | 0.112 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.726334e-01 | 0.112 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.726334e-01 | 0.112 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.726334e-01 | 0.112 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.726334e-01 | 0.112 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.726334e-01 | 0.112 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.730126e-01 | 0.112 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.730126e-01 | 0.112 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.759091e-01 | 0.110 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.765280e-01 | 0.110 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.765280e-01 | 0.110 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.765280e-01 | 0.110 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.765280e-01 | 0.110 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.765280e-01 | 0.110 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.770901e-01 | 0.110 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.770901e-01 | 0.110 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.814854e-01 | 0.107 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.814854e-01 | 0.107 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.814854e-01 | 0.107 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.814854e-01 | 0.107 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.825383e-01 | 0.106 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.830685e-01 | 0.106 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.832375e-01 | 0.106 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.848212e-01 | 0.105 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.867505e-01 | 0.104 | 1 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.884158e-01 | 0.103 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.884158e-01 | 0.103 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.919408e-01 | 0.101 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.919408e-01 | 0.101 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.925640e-01 | 0.101 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.928338e-01 | 0.101 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.928338e-01 | 0.101 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.928338e-01 | 0.101 | 1 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.936589e-01 | 0.100 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.937683e-01 | 0.100 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.952219e-01 | 0.100 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.952219e-01 | 0.100 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.952219e-01 | 0.100 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.952219e-01 | 0.100 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.952219e-01 | 0.100 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.952219e-01 | 0.100 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.952219e-01 | 0.100 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.952219e-01 | 0.100 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.952219e-01 | 0.100 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.952219e-01 | 0.100 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.960511e-01 | 0.099 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.960511e-01 | 0.099 | 1 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.960511e-01 | 0.099 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.971278e-01 | 0.098 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.971278e-01 | 0.098 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.971278e-01 | 0.098 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 7.971278e-01 | 0.098 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.971278e-01 | 0.098 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.971278e-01 | 0.098 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.971278e-01 | 0.098 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.971278e-01 | 0.098 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.971278e-01 | 0.098 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.971278e-01 | 0.098 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.971278e-01 | 0.098 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.015872e-01 | 0.096 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.021833e-01 | 0.096 | 1 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.077085e-01 | 0.093 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.077085e-01 | 0.093 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.077085e-01 | 0.093 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.092246e-01 | 0.092 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.103437e-01 | 0.091 | 1 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.115740e-01 | 0.091 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.117885e-01 | 0.091 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.120357e-01 | 0.090 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.120357e-01 | 0.090 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.120357e-01 | 0.090 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.136584e-01 | 0.090 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.183826e-01 | 0.087 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.189847e-01 | 0.087 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.189847e-01 | 0.087 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.189847e-01 | 0.087 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.189847e-01 | 0.087 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.189847e-01 | 0.087 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.189847e-01 | 0.087 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.189847e-01 | 0.087 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.189847e-01 | 0.087 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.189847e-01 | 0.087 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.189847e-01 | 0.087 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.226772e-01 | 0.085 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.226772e-01 | 0.085 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.259360e-01 | 0.083 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.259360e-01 | 0.083 | 1 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.270316e-01 | 0.082 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.273903e-01 | 0.082 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.276049e-01 | 0.082 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.276049e-01 | 0.082 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.276049e-01 | 0.082 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.276049e-01 | 0.082 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.276049e-01 | 0.082 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.276049e-01 | 0.082 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.289976e-01 | 0.081 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.329341e-01 | 0.079 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.329341e-01 | 0.079 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.329341e-01 | 0.079 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.330511e-01 | 0.079 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.330511e-01 | 0.079 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.361032e-01 | 0.078 | 1 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.375531e-01 | 0.077 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.384879e-01 | 0.077 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.384879e-01 | 0.077 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.384879e-01 | 0.077 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.384879e-01 | 0.077 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.384879e-01 | 0.077 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.384879e-01 | 0.077 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.384879e-01 | 0.077 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.384879e-01 | 0.077 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.384879e-01 | 0.077 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.384879e-01 | 0.077 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.384879e-01 | 0.077 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.384879e-01 | 0.077 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.384879e-01 | 0.077 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.384879e-01 | 0.077 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.384879e-01 | 0.077 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.384879e-01 | 0.077 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.384879e-01 | 0.077 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.384879e-01 | 0.077 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.384879e-01 | 0.077 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.384879e-01 | 0.077 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.384879e-01 | 0.077 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.384879e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.404884e-01 | 0.075 | 1 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.413099e-01 | 0.075 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.420025e-01 | 0.075 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.421717e-01 | 0.075 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.421717e-01 | 0.075 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.421717e-01 | 0.075 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.431029e-01 | 0.074 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.431029e-01 | 0.074 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.449630e-01 | 0.073 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.449630e-01 | 0.073 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.449630e-01 | 0.073 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.466987e-01 | 0.072 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.466987e-01 | 0.072 | 1 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.505268e-01 | 0.070 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.523105e-01 | 0.069 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.523105e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.523105e-01 | 0.069 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.523105e-01 | 0.069 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.524414e-01 | 0.069 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.524414e-01 | 0.069 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.526062e-01 | 0.069 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.526683e-01 | 0.069 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.549574e-01 | 0.068 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.553001e-01 | 0.068 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.553001e-01 | 0.068 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.553001e-01 | 0.068 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.553001e-01 | 0.068 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.553001e-01 | 0.068 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.553001e-01 | 0.068 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.558908e-01 | 0.068 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.558908e-01 | 0.068 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.558908e-01 | 0.068 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.558908e-01 | 0.068 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.558908e-01 | 0.068 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.558908e-01 | 0.068 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.558908e-01 | 0.068 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.558908e-01 | 0.068 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.558908e-01 | 0.068 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.558908e-01 | 0.068 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.558908e-01 | 0.068 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.558908e-01 | 0.068 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.558908e-01 | 0.068 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.558908e-01 | 0.068 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.558908e-01 | 0.068 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.558908e-01 | 0.068 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.558908e-01 | 0.068 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.558908e-01 | 0.068 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.558908e-01 | 0.068 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.558908e-01 | 0.068 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.562325e-01 | 0.067 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.562325e-01 | 0.067 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.576694e-01 | 0.067 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.576694e-01 | 0.067 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.576694e-01 | 0.067 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.605647e-01 | 0.065 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.621382e-01 | 0.064 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.621382e-01 | 0.064 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.622182e-01 | 0.064 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.641335e-01 | 0.063 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.667783e-01 | 0.062 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.667783e-01 | 0.062 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.675676e-01 | 0.062 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.686311e-01 | 0.061 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.692715e-01 | 0.061 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.696847e-01 | 0.061 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.711345e-01 | 0.060 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.712843e-01 | 0.060 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.714194e-01 | 0.060 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.714194e-01 | 0.060 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.714194e-01 | 0.060 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.714194e-01 | 0.060 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.714194e-01 | 0.060 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.714194e-01 | 0.060 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.714194e-01 | 0.060 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.714194e-01 | 0.060 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.714194e-01 | 0.060 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.714194e-01 | 0.060 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.714194e-01 | 0.060 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.714194e-01 | 0.060 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.714194e-01 | 0.060 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.714194e-01 | 0.060 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.714194e-01 | 0.060 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.714194e-01 | 0.060 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.714194e-01 | 0.060 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.714194e-01 | 0.060 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.714194e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.714194e-01 | 0.060 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.752297e-01 | 0.058 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.766359e-01 | 0.057 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.766359e-01 | 0.057 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.776555e-01 | 0.057 | 1 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.777036e-01 | 0.057 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.788724e-01 | 0.056 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.788724e-01 | 0.056 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.788724e-01 | 0.056 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.788724e-01 | 0.056 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.799023e-01 | 0.056 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.847516e-01 | 0.053 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.852756e-01 | 0.053 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.852756e-01 | 0.053 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.852756e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.852756e-01 | 0.053 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.852756e-01 | 0.053 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.852756e-01 | 0.053 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.852756e-01 | 0.053 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.852756e-01 | 0.053 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.852756e-01 | 0.053 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.852756e-01 | 0.053 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.852756e-01 | 0.053 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.852756e-01 | 0.053 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.852756e-01 | 0.053 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.881668e-01 | 0.052 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.892797e-01 | 0.051 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.892797e-01 | 0.051 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.892797e-01 | 0.051 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.892797e-01 | 0.051 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.893746e-01 | 0.051 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.914964e-01 | 0.050 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.930166e-01 | 0.049 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.931250e-01 | 0.049 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.944262e-01 | 0.048 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.959437e-01 | 0.048 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.976393e-01 | 0.047 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.976393e-01 | 0.047 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.976393e-01 | 0.047 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.976393e-01 | 0.047 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.976393e-01 | 0.047 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.976393e-01 | 0.047 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.976393e-01 | 0.047 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.976393e-01 | 0.047 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.976393e-01 | 0.047 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.976393e-01 | 0.047 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.978997e-01 | 0.047 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.988514e-01 | 0.046 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.988514e-01 | 0.046 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.992797e-01 | 0.046 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.003059e-01 | 0.046 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.036415e-01 | 0.044 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.042206e-01 | 0.044 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.054232e-01 | 0.043 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.076468e-01 | 0.042 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.076468e-01 | 0.042 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.076468e-01 | 0.042 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.076468e-01 | 0.042 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.086712e-01 | 0.042 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.086712e-01 | 0.042 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.086712e-01 | 0.042 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.086712e-01 | 0.042 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.086712e-01 | 0.042 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.086712e-01 | 0.042 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.086712e-01 | 0.042 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.086712e-01 | 0.042 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.086712e-01 | 0.042 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.095413e-01 | 0.041 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.095413e-01 | 0.041 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.097455e-01 | 0.041 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.097455e-01 | 0.041 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.098764e-01 | 0.041 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.117194e-01 | 0.040 | 1 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.117620e-01 | 0.040 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.139946e-01 | 0.039 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.149952e-01 | 0.039 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.158529e-01 | 0.038 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.158529e-01 | 0.038 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.168054e-01 | 0.038 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.168054e-01 | 0.038 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.175950e-01 | 0.037 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.185147e-01 | 0.037 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.185147e-01 | 0.037 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.185147e-01 | 0.037 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.185147e-01 | 0.037 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.185147e-01 | 0.037 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.185147e-01 | 0.037 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.185147e-01 | 0.037 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.185147e-01 | 0.037 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.185147e-01 | 0.037 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.185147e-01 | 0.037 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.185147e-01 | 0.037 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.185147e-01 | 0.037 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.203797e-01 | 0.036 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.231300e-01 | 0.035 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.231300e-01 | 0.035 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.237866e-01 | 0.034 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.272979e-01 | 0.033 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.272979e-01 | 0.033 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.272979e-01 | 0.033 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.272979e-01 | 0.033 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.272979e-01 | 0.033 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.272979e-01 | 0.033 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.272979e-01 | 0.033 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.272979e-01 | 0.033 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.272979e-01 | 0.033 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.272979e-01 | 0.033 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.273070e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.277633e-01 | 0.033 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.292254e-01 | 0.032 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.299208e-01 | 0.032 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.324898e-01 | 0.030 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.326995e-01 | 0.030 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.332829e-01 | 0.030 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.351347e-01 | 0.029 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.351347e-01 | 0.029 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.351347e-01 | 0.029 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.351347e-01 | 0.029 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.351347e-01 | 0.029 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.351347e-01 | 0.029 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.351347e-01 | 0.029 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.351347e-01 | 0.029 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.353812e-01 | 0.029 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.359189e-01 | 0.029 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.361105e-01 | 0.029 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.361413e-01 | 0.029 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.361413e-01 | 0.029 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.399192e-01 | 0.027 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.418356e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.418356e-01 | 0.026 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.418633e-01 | 0.026 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.421272e-01 | 0.026 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.421272e-01 | 0.026 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.421272e-01 | 0.026 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.421272e-01 | 0.026 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.421272e-01 | 0.026 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.421272e-01 | 0.026 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.421759e-01 | 0.026 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.430516e-01 | 0.025 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.439524e-01 | 0.025 | 1 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.458309e-01 | 0.024 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.459731e-01 | 0.024 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.470447e-01 | 0.024 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.472676e-01 | 0.024 | 1 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.483663e-01 | 0.023 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.483663e-01 | 0.023 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.483663e-01 | 0.023 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.483663e-01 | 0.023 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.483663e-01 | 0.023 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.483663e-01 | 0.023 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.483663e-01 | 0.023 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.483663e-01 | 0.023 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.483663e-01 | 0.023 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.490811e-01 | 0.023 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.490992e-01 | 0.023 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.500345e-01 | 0.022 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.500345e-01 | 0.022 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.518071e-01 | 0.021 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.518071e-01 | 0.021 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.518071e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.518071e-01 | 0.021 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.531824e-01 | 0.021 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.539331e-01 | 0.020 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.539331e-01 | 0.020 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.539331e-01 | 0.020 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.539331e-01 | 0.020 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.558339e-01 | 0.020 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.561585e-01 | 0.019 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.561585e-01 | 0.019 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.561585e-01 | 0.019 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.561585e-01 | 0.019 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.588942e-01 | 0.018 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.589000e-01 | 0.018 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.589000e-01 | 0.018 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.589000e-01 | 0.018 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.589000e-01 | 0.018 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.589000e-01 | 0.018 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.589000e-01 | 0.018 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.589000e-01 | 0.018 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.589000e-01 | 0.018 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.589000e-01 | 0.018 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.596765e-01 | 0.018 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.596765e-01 | 0.018 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.601322e-01 | 0.018 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.601322e-01 | 0.018 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.601322e-01 | 0.018 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.601322e-01 | 0.018 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.601322e-01 | 0.018 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.605211e-01 | 0.017 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.633316e-01 | 0.016 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.633316e-01 | 0.016 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.633316e-01 | 0.016 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.633316e-01 | 0.016 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.633316e-01 | 0.016 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.633316e-01 | 0.016 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.633316e-01 | 0.016 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.633316e-01 | 0.016 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.633316e-01 | 0.016 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.633316e-01 | 0.016 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.636679e-01 | 0.016 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.637590e-01 | 0.016 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.644177e-01 | 0.016 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.647934e-01 | 0.016 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.652710e-01 | 0.015 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.660605e-01 | 0.015 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.670675e-01 | 0.015 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.670675e-01 | 0.015 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.672856e-01 | 0.014 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.672856e-01 | 0.014 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.672856e-01 | 0.014 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.672856e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.672856e-01 | 0.014 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.672856e-01 | 0.014 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.680419e-01 | 0.014 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.700841e-01 | 0.013 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.700841e-01 | 0.013 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.705663e-01 | 0.013 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.708135e-01 | 0.013 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.708135e-01 | 0.013 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.708135e-01 | 0.013 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.708135e-01 | 0.013 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.708135e-01 | 0.013 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.708135e-01 | 0.013 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.708135e-01 | 0.013 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.708135e-01 | 0.013 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.728333e-01 | 0.012 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.728333e-01 | 0.012 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.728333e-01 | 0.012 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.732274e-01 | 0.012 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.739611e-01 | 0.011 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.739611e-01 | 0.011 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.739611e-01 | 0.011 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.739611e-01 | 0.011 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.739611e-01 | 0.011 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.739611e-01 | 0.011 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.742412e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.753377e-01 | 0.011 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.753377e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.753377e-01 | 0.011 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.753377e-01 | 0.011 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.753377e-01 | 0.011 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.753377e-01 | 0.011 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.767694e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.767694e-01 | 0.010 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.767694e-01 | 0.010 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.767694e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.767694e-01 | 0.010 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.767694e-01 | 0.010 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.767694e-01 | 0.010 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.771887e-01 | 0.010 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.789559e-01 | 0.009 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.792750e-01 | 0.009 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.792750e-01 | 0.009 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.796937e-01 | 0.009 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.798945e-01 | 0.009 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.801774e-01 | 0.009 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.803900e-01 | 0.009 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.808474e-01 | 0.008 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.815105e-01 | 0.008 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.815105e-01 | 0.008 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.815105e-01 | 0.008 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.815105e-01 | 0.008 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.815105e-01 | 0.008 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.815821e-01 | 0.008 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.818406e-01 | 0.008 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.821811e-01 | 0.008 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.829588e-01 | 0.007 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.832995e-01 | 0.007 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.832995e-01 | 0.007 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.835050e-01 | 0.007 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.835050e-01 | 0.007 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.835050e-01 | 0.007 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.835139e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.839793e-01 | 0.007 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.839793e-01 | 0.007 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.839793e-01 | 0.007 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.844237e-01 | 0.007 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.847936e-01 | 0.007 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.847936e-01 | 0.007 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.848130e-01 | 0.007 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.848608e-01 | 0.007 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.848608e-01 | 0.007 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.852844e-01 | 0.006 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.852844e-01 | 0.006 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.852844e-01 | 0.006 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.852844e-01 | 0.006 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.852844e-01 | 0.006 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.852844e-01 | 0.006 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.860145e-01 | 0.006 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.860890e-01 | 0.006 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.862798e-01 | 0.006 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.868719e-01 | 0.006 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.868719e-01 | 0.006 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.870905e-01 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.871252e-01 | 0.006 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.874877e-01 | 0.005 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.875689e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.875689e-01 | 0.005 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.875689e-01 | 0.005 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.881517e-01 | 0.005 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.881517e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.881517e-01 | 0.005 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.882883e-01 | 0.005 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.887396e-01 | 0.005 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.895520e-01 | 0.005 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.895520e-01 | 0.005 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.895520e-01 | 0.005 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.902491e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.902491e-01 | 0.004 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.902871e-01 | 0.004 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.903743e-01 | 0.004 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.906793e-01 | 0.004 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.906793e-01 | 0.004 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.906793e-01 | 0.004 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.906793e-01 | 0.004 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.906793e-01 | 0.004 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.906793e-01 | 0.004 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.906793e-01 | 0.004 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.906793e-01 | 0.004 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.906793e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.907672e-01 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.907672e-01 | 0.004 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.908332e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.909334e-01 | 0.004 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.915857e-01 | 0.004 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.916426e-01 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.916851e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.916851e-01 | 0.004 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.924366e-01 | 0.003 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.925824e-01 | 0.003 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.925824e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.932496e-01 | 0.003 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.933829e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.933829e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.933829e-01 | 0.003 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.933829e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.938093e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.938093e-01 | 0.003 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.940971e-01 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.940971e-01 | 0.003 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.944834e-01 | 0.002 | 1 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.947342e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.947342e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.947342e-01 | 0.002 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.949370e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.949370e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.949370e-01 | 0.002 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.953026e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.953026e-01 | 0.002 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.954830e-01 | 0.002 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.958097e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.958097e-01 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.958097e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.958625e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.958625e-01 | 0.002 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.958625e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.958625e-01 | 0.002 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.959038e-01 | 0.002 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.960849e-01 | 0.002 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.962453e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.962607e-01 | 0.002 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.966656e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.966656e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.966656e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.966656e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.967796e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.968737e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.969474e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.969874e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.970256e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.970256e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.970256e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.970305e-01 | 0.001 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.973298e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.973467e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.974465e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.974465e-01 | 0.001 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.976332e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.976332e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.976332e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.977549e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.981168e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.981673e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.981673e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.981673e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.981673e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.982067e-01 | 0.001 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.983336e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.983459e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.985016e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.985016e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.985016e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.986231e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.986446e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.987181e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.987848e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.987848e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.988078e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.988078e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.989269e-01 | 0.000 | 1 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.990113e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.990515e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.990610e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.992804e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.993269e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.993270e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.994110e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.995215e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.995224e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.995689e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.995740e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.995740e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.996200e-01 | 0.000 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.996200e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.996436e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.996474e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.996977e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997387e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.997596e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.997927e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998019e-01 | 0.000 | 1 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.998134e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.998320e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998790e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998790e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.998850e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998921e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999104e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999108e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999234e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999291e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999350e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999391e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999391e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999399e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999445e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.999457e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999527e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999597e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999615e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999727e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999750e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999784e-01 | 0.000 | 1 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999806e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999816e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999869e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999878e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999884e-01 | 0.000 | 1 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999894e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999916e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999941e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999983e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999985e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999988e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999988e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999990e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999991e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999991e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999992e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999996e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999997e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999998e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999998e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 2.049139e-12 | 11.688 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.848322e-12 | 11.233 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.739719e-11 | 10.760 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.601663e-11 | 10.585 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.374354e-10 | 9.359 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.014893e-10 | 9.300 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.150978e-09 | 8.939 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.871996e-09 | 8.542 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.856235e-09 | 8.414 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.257532e-08 | 7.646 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.932128e-08 | 7.533 | 1 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.106530e-07 | 6.956 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.375839e-07 | 6.624 | 1 | 0 |
| M Phase | R-HSA-68886 | 2.783020e-07 | 6.555 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.506374e-07 | 6.455 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.406167e-07 | 6.356 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.196645e-07 | 6.284 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.180547e-07 | 6.286 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.748547e-07 | 6.240 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.748547e-07 | 6.240 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.019153e-07 | 6.220 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.407448e-07 | 6.193 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.601265e-07 | 6.018 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.379842e-07 | 6.028 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.177807e-07 | 6.037 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.050697e-06 | 5.979 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.085980e-06 | 5.964 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.570606e-06 | 5.804 | 1 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.032977e-06 | 5.692 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.032977e-06 | 5.692 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.415024e-06 | 5.617 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.559409e-06 | 5.592 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.559409e-06 | 5.592 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.083290e-06 | 5.511 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.757060e-06 | 5.323 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.772162e-06 | 5.321 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.926588e-06 | 5.227 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.829808e-06 | 5.234 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.849391e-06 | 5.233 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.847644e-06 | 5.164 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.231052e-06 | 5.035 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.587566e-06 | 5.018 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.018955e-05 | 4.992 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.329044e-05 | 4.876 | 1 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.689811e-05 | 4.772 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.910956e-05 | 4.719 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.075420e-05 | 4.683 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.101123e-05 | 4.678 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.142608e-05 | 4.669 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.290398e-05 | 4.640 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.335636e-05 | 4.632 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.751941e-05 | 4.560 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.835767e-05 | 4.547 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.835767e-05 | 4.547 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.122254e-05 | 4.506 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.758739e-05 | 4.425 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.843949e-05 | 4.415 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.890668e-05 | 4.410 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.063528e-05 | 4.391 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.591540e-05 | 4.338 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.612296e-05 | 4.336 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.758663e-05 | 4.323 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.197224e-05 | 4.284 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.978425e-05 | 4.303 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.155158e-05 | 4.288 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.197224e-05 | 4.284 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.998793e-05 | 4.301 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.450840e-05 | 4.264 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.701344e-05 | 4.244 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.087940e-05 | 4.216 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.159361e-05 | 4.210 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.506052e-05 | 4.187 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.473843e-05 | 4.189 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.759913e-05 | 4.170 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.644210e-05 | 4.117 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.070230e-05 | 4.093 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.006330e-04 | 3.997 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.027757e-04 | 3.988 | 1 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.054510e-04 | 3.977 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.228590e-04 | 3.911 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.276230e-04 | 3.894 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.800512e-04 | 3.745 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.824036e-04 | 3.739 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.955776e-04 | 3.709 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.902357e-04 | 3.721 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.985492e-04 | 3.702 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.175006e-04 | 3.663 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.304393e-04 | 3.637 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.428129e-04 | 3.615 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.456207e-04 | 3.610 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.368792e-04 | 3.625 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.765737e-04 | 3.558 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.846738e-04 | 3.546 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.921216e-04 | 3.534 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.258596e-04 | 3.487 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.284136e-04 | 3.484 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.693883e-04 | 3.433 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.172618e-04 | 3.380 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.480467e-04 | 3.349 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.225285e-04 | 3.374 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.225285e-04 | 3.374 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.225285e-04 | 3.374 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.480467e-04 | 3.349 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.225285e-04 | 3.374 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.571219e-04 | 3.340 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.974334e-04 | 3.303 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.300952e-04 | 3.276 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.649923e-04 | 3.248 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.637971e-04 | 3.249 | 1 | 1 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.707879e-04 | 3.244 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.727532e-04 | 3.242 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.741972e-04 | 3.241 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.885550e-04 | 3.230 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.306424e-04 | 3.200 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.501735e-04 | 3.187 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.501735e-04 | 3.187 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.569398e-04 | 3.182 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.628967e-04 | 3.179 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.881217e-04 | 3.162 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.600719e-04 | 3.119 | 1 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.351666e-04 | 3.134 | 1 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.622230e-04 | 3.118 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.666151e-04 | 3.115 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.254163e-04 | 3.083 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.384031e-04 | 3.028 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.810422e-04 | 3.008 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.002365e-03 | 2.999 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.002365e-03 | 2.999 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.146627e-03 | 2.941 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.100007e-03 | 2.959 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.184192e-03 | 2.927 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.209074e-03 | 2.918 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.352313e-03 | 2.869 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.427670e-03 | 2.845 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.548610e-03 | 2.810 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.548783e-03 | 2.810 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.655411e-03 | 2.781 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.690539e-03 | 2.772 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.708027e-03 | 2.768 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.708027e-03 | 2.768 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.723197e-03 | 2.764 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.026260e-03 | 2.693 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.042387e-03 | 2.690 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.042387e-03 | 2.690 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.111322e-03 | 2.675 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.210987e-03 | 2.655 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.219871e-03 | 2.654 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.227259e-03 | 2.652 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.227259e-03 | 2.652 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.618567e-03 | 2.582 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.880066e-03 | 2.541 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.944736e-03 | 2.531 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.161768e-03 | 2.500 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.434632e-03 | 2.464 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.980550e-03 | 2.400 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.852793e-03 | 2.414 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.793049e-03 | 2.421 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.004916e-03 | 2.397 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.102904e-03 | 2.387 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.227364e-03 | 2.374 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.227364e-03 | 2.374 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.228884e-03 | 2.374 | 1 | 1 |
| Telomere Maintenance | R-HSA-157579 | 4.230662e-03 | 2.374 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.402467e-03 | 2.356 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.598799e-03 | 2.337 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.345753e-03 | 2.272 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.107566e-03 | 2.292 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.345753e-03 | 2.272 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.828554e-03 | 2.316 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.948345e-03 | 2.306 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.319256e-03 | 2.274 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.994512e-03 | 2.302 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.096441e-03 | 2.293 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.345753e-03 | 2.272 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.620843e-03 | 2.250 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.879021e-03 | 2.231 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.040219e-03 | 2.219 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.099569e-03 | 2.215 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.351070e-03 | 2.197 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.550180e-03 | 2.184 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.624272e-03 | 2.179 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.719145e-03 | 2.173 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.979627e-03 | 2.156 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.979627e-03 | 2.156 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.014840e-03 | 2.154 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.417034e-03 | 2.130 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.462280e-03 | 2.127 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.462280e-03 | 2.127 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.462280e-03 | 2.127 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.462280e-03 | 2.127 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.469700e-03 | 2.127 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.140160e-03 | 2.089 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.598284e-03 | 2.066 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.156565e-03 | 2.088 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.762964e-03 | 2.057 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.762964e-03 | 2.057 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.764847e-03 | 2.057 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.184461e-03 | 2.037 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.695822e-03 | 2.013 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.831986e-03 | 2.007 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.955624e-03 | 2.002 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.006747e-02 | 1.997 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.033009e-02 | 1.986 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.043264e-02 | 1.982 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.050886e-02 | 1.978 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.103131e-02 | 1.957 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.134399e-02 | 1.945 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.134399e-02 | 1.945 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.181219e-02 | 1.928 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.251933e-02 | 1.902 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.251933e-02 | 1.902 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.297508e-02 | 1.887 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.299723e-02 | 1.886 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.310893e-02 | 1.882 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.310893e-02 | 1.882 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.381320e-02 | 1.860 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.381320e-02 | 1.860 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.381320e-02 | 1.860 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.381320e-02 | 1.860 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.381320e-02 | 1.860 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.372549e-02 | 1.862 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.464952e-02 | 1.834 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.443693e-02 | 1.841 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.459689e-02 | 1.836 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.569935e-02 | 1.804 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.595845e-02 | 1.797 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.605002e-02 | 1.795 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.620002e-02 | 1.790 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.663673e-02 | 1.779 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.712468e-02 | 1.766 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.712468e-02 | 1.766 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.712468e-02 | 1.766 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.746933e-02 | 1.758 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.822047e-02 | 1.739 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.842206e-02 | 1.735 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.844261e-02 | 1.734 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.894002e-02 | 1.723 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.170870e-02 | 1.663 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.266474e-02 | 1.645 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.276906e-02 | 1.643 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.285454e-02 | 1.641 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.330904e-02 | 1.632 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.368060e-02 | 1.626 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.372701e-02 | 1.625 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.410202e-02 | 1.618 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.421892e-02 | 1.616 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.421892e-02 | 1.616 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.442829e-02 | 1.612 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.934070e-02 | 1.533 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.478081e-02 | 1.606 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.917954e-02 | 1.535 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.917954e-02 | 1.535 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.792407e-02 | 1.554 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.893516e-02 | 1.539 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.753663e-02 | 1.560 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.799491e-02 | 1.553 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.670603e-02 | 1.573 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.670603e-02 | 1.573 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.670603e-02 | 1.573 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.917954e-02 | 1.535 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.934070e-02 | 1.533 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.893516e-02 | 1.539 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.650999e-02 | 1.577 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.927925e-02 | 1.533 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.792407e-02 | 1.554 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.494932e-02 | 1.603 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.936575e-02 | 1.532 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.115422e-02 | 1.506 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.208016e-02 | 1.494 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.307010e-02 | 1.481 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.338895e-02 | 1.476 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.365481e-02 | 1.473 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.430788e-02 | 1.465 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.466329e-02 | 1.460 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.470852e-02 | 1.460 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.489827e-02 | 1.457 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.508900e-02 | 1.455 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.522292e-02 | 1.453 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.532419e-02 | 1.452 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.582069e-02 | 1.446 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.669467e-02 | 1.435 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.669467e-02 | 1.435 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.669467e-02 | 1.435 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.669467e-02 | 1.435 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.669467e-02 | 1.435 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.701629e-02 | 1.432 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.724667e-02 | 1.429 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.863348e-02 | 1.413 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.896179e-02 | 1.409 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.934400e-02 | 1.405 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.934400e-02 | 1.405 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.118204e-02 | 1.385 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.168322e-02 | 1.380 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.195059e-02 | 1.377 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.377481e-02 | 1.359 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.926444e-02 | 1.307 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.926444e-02 | 1.307 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.926444e-02 | 1.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.926444e-02 | 1.307 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.522200e-02 | 1.345 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.476060e-02 | 1.262 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.476060e-02 | 1.262 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.476060e-02 | 1.262 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.476060e-02 | 1.262 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.476060e-02 | 1.262 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.567544e-02 | 1.340 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.297779e-02 | 1.276 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.944798e-02 | 1.306 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.839253e-02 | 1.315 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.221069e-02 | 1.282 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.373940e-02 | 1.270 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.373940e-02 | 1.270 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.926444e-02 | 1.307 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.522200e-02 | 1.345 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.476060e-02 | 1.262 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.289806e-02 | 1.277 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.221069e-02 | 1.282 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.716779e-02 | 1.326 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.496954e-02 | 1.260 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.496954e-02 | 1.260 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.504646e-02 | 1.259 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.974151e-02 | 1.224 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.028843e-02 | 1.220 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.028843e-02 | 1.220 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.028843e-02 | 1.220 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.051487e-02 | 1.218 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.347176e-02 | 1.197 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.372644e-02 | 1.196 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.529779e-02 | 1.185 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.606589e-02 | 1.180 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.666269e-02 | 1.176 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.755917e-02 | 1.170 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.831700e-02 | 1.165 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.058358e-02 | 1.151 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.187405e-02 | 1.143 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 7.273333e-02 | 1.138 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 7.273333e-02 | 1.138 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.307009e-02 | 1.136 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.409254e-02 | 1.130 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.468324e-02 | 1.127 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.468324e-02 | 1.127 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.472229e-02 | 1.127 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.472229e-02 | 1.127 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.534354e-02 | 1.123 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.749216e-02 | 1.111 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.780856e-02 | 1.109 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.986335e-02 | 1.098 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.255633e-02 | 1.083 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.255633e-02 | 1.083 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.331102e-02 | 1.079 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.331102e-02 | 1.079 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.435172e-02 | 1.074 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 8.435172e-02 | 1.074 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.671218e-02 | 1.062 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.687379e-02 | 1.061 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.786408e-02 | 1.056 | 1 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.807606e-02 | 1.055 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.926592e-02 | 1.049 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.926592e-02 | 1.049 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.926592e-02 | 1.049 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.985455e-02 | 1.046 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.109672e-02 | 1.040 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.109672e-02 | 1.040 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.109672e-02 | 1.040 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.311569e-02 | 1.031 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.311569e-02 | 1.031 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.311569e-02 | 1.031 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 9.900836e-02 | 1.004 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 9.900836e-02 | 1.004 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 9.900836e-02 | 1.004 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 9.900836e-02 | 1.004 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.088554e-01 | 0.963 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.088554e-01 | 0.963 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.168367e-01 | 0.932 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.168367e-01 | 0.932 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.020491e-01 | 0.991 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.121785e-01 | 0.950 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.121785e-01 | 0.950 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.800027e-02 | 1.009 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.256466e-01 | 0.901 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.022433e-01 | 0.990 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.022433e-01 | 0.990 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.080431e-01 | 0.966 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.217380e-01 | 0.915 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.982282e-02 | 1.001 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.256466e-01 | 0.901 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.256466e-01 | 0.901 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.444437e-02 | 1.025 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.088554e-01 | 0.963 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.160280e-01 | 0.935 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.006253e-01 | 0.997 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.227974e-01 | 0.911 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.191848e-01 | 0.924 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.039378e-01 | 0.983 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.256466e-01 | 0.901 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.256466e-01 | 0.901 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.147454e-01 | 0.940 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.256466e-01 | 0.901 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.496525e-02 | 1.022 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.554487e-02 | 1.020 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.043401e-01 | 0.982 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.117028e-01 | 0.952 | 1 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.174492e-01 | 0.930 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.160280e-01 | 0.935 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.020491e-01 | 0.991 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.129890e-01 | 0.947 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.174492e-01 | 0.930 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.020491e-01 | 0.991 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.274499e-01 | 0.895 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.274499e-01 | 0.895 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.274499e-01 | 0.895 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.278242e-01 | 0.893 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.286322e-01 | 0.891 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.286322e-01 | 0.891 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.316913e-01 | 0.880 | 1 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.318516e-01 | 0.880 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.318516e-01 | 0.880 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.318516e-01 | 0.880 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.318516e-01 | 0.880 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.338897e-01 | 0.873 | 1 | 1 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.338897e-01 | 0.873 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.356550e-01 | 0.868 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.358343e-01 | 0.867 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.376663e-01 | 0.861 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.396634e-01 | 0.855 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.396634e-01 | 0.855 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.398439e-01 | 0.854 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.398439e-01 | 0.854 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.403511e-01 | 0.853 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.416647e-01 | 0.849 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.416647e-01 | 0.849 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.425742e-01 | 0.846 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.425786e-01 | 0.846 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.425786e-01 | 0.846 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.448447e-01 | 0.839 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.454376e-01 | 0.837 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.454376e-01 | 0.837 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.462010e-01 | 0.835 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.476110e-01 | 0.831 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.476110e-01 | 0.831 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 1.476110e-01 | 0.831 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 1.476110e-01 | 0.831 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.476110e-01 | 0.831 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.478641e-01 | 0.830 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.483464e-01 | 0.829 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.515177e-01 | 0.820 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.531608e-01 | 0.815 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.547904e-01 | 0.810 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.567918e-01 | 0.805 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.615928e-01 | 0.792 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.615928e-01 | 0.792 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.615928e-01 | 0.792 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.615928e-01 | 0.792 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.615928e-01 | 0.792 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.615928e-01 | 0.792 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.615928e-01 | 0.792 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.615928e-01 | 0.792 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.323223e-01 | 0.634 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.323223e-01 | 0.634 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.323223e-01 | 0.634 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.323223e-01 | 0.634 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.323223e-01 | 0.634 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.323223e-01 | 0.634 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.323223e-01 | 0.634 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.323223e-01 | 0.634 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.323223e-01 | 0.634 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.575060e-01 | 0.803 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.575060e-01 | 0.803 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 1.575060e-01 | 0.803 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.575060e-01 | 0.803 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 1.575060e-01 | 0.803 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.575060e-01 | 0.803 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.887025e-01 | 0.724 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.206335e-01 | 0.656 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.206335e-01 | 0.656 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.206335e-01 | 0.656 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.206335e-01 | 0.656 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.206335e-01 | 0.656 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.688343e-01 | 0.773 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.905957e-01 | 0.720 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.987350e-01 | 0.702 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.987350e-01 | 0.702 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.987350e-01 | 0.702 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.693345e-01 | 0.771 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.839016e-01 | 0.735 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.839016e-01 | 0.735 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.698190e-01 | 0.770 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.989072e-01 | 0.701 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.353728e-01 | 0.628 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.143126e-01 | 0.669 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.750249e-01 | 0.757 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.154699e-01 | 0.667 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.867849e-01 | 0.729 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.092626e-01 | 0.679 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.191362e-01 | 0.659 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.704167e-01 | 0.768 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.092626e-01 | 0.679 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.957645e-01 | 0.708 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.811170e-01 | 0.742 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.077324e-01 | 0.682 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.910809e-01 | 0.719 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.171823e-01 | 0.663 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.574212e-01 | 0.803 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.575060e-01 | 0.803 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.130125e-01 | 0.672 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.216571e-01 | 0.654 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.599550e-01 | 0.796 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.952349e-01 | 0.709 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.350894e-01 | 0.629 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.077324e-01 | 0.682 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.323223e-01 | 0.634 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.323223e-01 | 0.634 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.323223e-01 | 0.634 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.206335e-01 | 0.656 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.678926e-01 | 0.775 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.126387e-01 | 0.672 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.740710e-01 | 0.759 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.666644e-01 | 0.778 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.120310e-01 | 0.674 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.154699e-01 | 0.667 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.811170e-01 | 0.742 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.779703e-01 | 0.750 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.887025e-01 | 0.724 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.031344e-01 | 0.692 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.206426e-01 | 0.656 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.130125e-01 | 0.672 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.905957e-01 | 0.720 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.905957e-01 | 0.720 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.989072e-01 | 0.701 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.130125e-01 | 0.672 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.875201e-01 | 0.727 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.780205e-01 | 0.750 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.353728e-01 | 0.628 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.206335e-01 | 0.656 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.300782e-01 | 0.638 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.578651e-01 | 0.802 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.910809e-01 | 0.719 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.693345e-01 | 0.771 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.575060e-01 | 0.803 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.092626e-01 | 0.679 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.168422e-01 | 0.664 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.989072e-01 | 0.701 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.864649e-01 | 0.729 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.226741e-01 | 0.652 | 1 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.905957e-01 | 0.720 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.359538e-01 | 0.627 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.359538e-01 | 0.627 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.359538e-01 | 0.627 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.359538e-01 | 0.627 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.371792e-01 | 0.625 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.414319e-01 | 0.617 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.425212e-01 | 0.615 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.461640e-01 | 0.609 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.461640e-01 | 0.609 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.470026e-01 | 0.607 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.492895e-01 | 0.603 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.515437e-01 | 0.599 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.515437e-01 | 0.599 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.518966e-01 | 0.599 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.529534e-01 | 0.597 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.529534e-01 | 0.597 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.529534e-01 | 0.597 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.529534e-01 | 0.597 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.529534e-01 | 0.597 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.529534e-01 | 0.597 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.539769e-01 | 0.595 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.542613e-01 | 0.595 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.542613e-01 | 0.595 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.592945e-01 | 0.586 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.592945e-01 | 0.586 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.592945e-01 | 0.586 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.592945e-01 | 0.586 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.625297e-01 | 0.581 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.625297e-01 | 0.581 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.625297e-01 | 0.581 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.636946e-01 | 0.579 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.661422e-01 | 0.575 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.661422e-01 | 0.575 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.665669e-01 | 0.574 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.668712e-01 | 0.574 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.668712e-01 | 0.574 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.715388e-01 | 0.566 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.734437e-01 | 0.563 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.734437e-01 | 0.563 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.734437e-01 | 0.563 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.970888e-01 | 0.527 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.970888e-01 | 0.527 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 2.970888e-01 | 0.527 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 2.970888e-01 | 0.527 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.970888e-01 | 0.527 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.563946e-01 | 0.448 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.563946e-01 | 0.448 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.563946e-01 | 0.448 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.563946e-01 | 0.448 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.563946e-01 | 0.448 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.563946e-01 | 0.448 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 3.563946e-01 | 0.448 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.853697e-01 | 0.545 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.853697e-01 | 0.545 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.107000e-01 | 0.386 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.107000e-01 | 0.386 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.176362e-01 | 0.498 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.495478e-01 | 0.456 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.604262e-01 | 0.337 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.604262e-01 | 0.337 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 4.604262e-01 | 0.337 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.604262e-01 | 0.337 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.604262e-01 | 0.337 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.604262e-01 | 0.337 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.604262e-01 | 0.337 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.067105e-01 | 0.513 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.809347e-01 | 0.419 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 3.809347e-01 | 0.419 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.809347e-01 | 0.419 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.809347e-01 | 0.419 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.809347e-01 | 0.419 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.305728e-01 | 0.481 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.124413e-01 | 0.505 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.544095e-01 | 0.450 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.116585e-01 | 0.385 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 4.116585e-01 | 0.385 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 4.116585e-01 | 0.385 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.059591e-01 | 0.296 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.059591e-01 | 0.296 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.059591e-01 | 0.296 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.059591e-01 | 0.296 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.059591e-01 | 0.296 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.059591e-01 | 0.296 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.059591e-01 | 0.296 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.059591e-01 | 0.296 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.059591e-01 | 0.296 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.059591e-01 | 0.296 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.959410e-01 | 0.529 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.321376e-01 | 0.479 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.321376e-01 | 0.479 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.716473e-01 | 0.430 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.913579e-01 | 0.407 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.706944e-01 | 0.327 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.476521e-01 | 0.261 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.476521e-01 | 0.261 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.476521e-01 | 0.261 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.476521e-01 | 0.261 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.476521e-01 | 0.261 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.476521e-01 | 0.261 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.476521e-01 | 0.261 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.476521e-01 | 0.261 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.478939e-01 | 0.349 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.988510e-01 | 0.302 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.988510e-01 | 0.302 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 4.988510e-01 | 0.302 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.240547e-01 | 0.489 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.692478e-01 | 0.433 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.594341e-01 | 0.444 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.926109e-01 | 0.307 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.926109e-01 | 0.307 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.260272e-01 | 0.279 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.260272e-01 | 0.279 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.260272e-01 | 0.279 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.226981e-01 | 0.374 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.354572e-01 | 0.271 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.870311e-01 | 0.312 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.045152e-01 | 0.297 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.781343e-01 | 0.422 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.067105e-01 | 0.513 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.781343e-01 | 0.422 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.993193e-01 | 0.302 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.829169e-01 | 0.548 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.928572e-01 | 0.533 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.823802e-01 | 0.418 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.809347e-01 | 0.419 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.988544e-01 | 0.399 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 3.305728e-01 | 0.481 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.941423e-01 | 0.531 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.876936e-01 | 0.312 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.950763e-01 | 0.305 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.176362e-01 | 0.498 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.809347e-01 | 0.419 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.816347e-01 | 0.418 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.478939e-01 | 0.349 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 2.959410e-01 | 0.529 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.305728e-01 | 0.481 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.604262e-01 | 0.337 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.305728e-01 | 0.481 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.059591e-01 | 0.296 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.299971e-01 | 0.481 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.988510e-01 | 0.302 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.354572e-01 | 0.271 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.809347e-01 | 0.419 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.109756e-01 | 0.386 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.124413e-01 | 0.505 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.604262e-01 | 0.337 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.604262e-01 | 0.337 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.604262e-01 | 0.337 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.416078e-01 | 0.355 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 4.706944e-01 | 0.327 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 5.476521e-01 | 0.261 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.354572e-01 | 0.271 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.895313e-01 | 0.409 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.044638e-01 | 0.516 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.829169e-01 | 0.548 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.086971e-01 | 0.389 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.917942e-01 | 0.535 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.354572e-01 | 0.271 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.604262e-01 | 0.337 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.706944e-01 | 0.327 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.348273e-01 | 0.475 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.497612e-01 | 0.347 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.887459e-01 | 0.539 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.124413e-01 | 0.505 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.770890e-01 | 0.557 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.172506e-01 | 0.499 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.476521e-01 | 0.261 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.926109e-01 | 0.307 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.416759e-01 | 0.466 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.044638e-01 | 0.516 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.304569e-01 | 0.366 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 4.249431e-01 | 0.372 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.716473e-01 | 0.430 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.263218e-01 | 0.486 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.809469e-01 | 0.551 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.800856e-01 | 0.319 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 2.970888e-01 | 0.527 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.970888e-01 | 0.527 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.563946e-01 | 0.448 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.563946e-01 | 0.448 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.829169e-01 | 0.548 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.495478e-01 | 0.456 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.604262e-01 | 0.337 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.604262e-01 | 0.337 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.305728e-01 | 0.481 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.544095e-01 | 0.450 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.059591e-01 | 0.296 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.809469e-01 | 0.551 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.518906e-01 | 0.454 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.263218e-01 | 0.486 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.476521e-01 | 0.261 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.922391e-01 | 0.534 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.478939e-01 | 0.349 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.260272e-01 | 0.279 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.315780e-01 | 0.274 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.026818e-01 | 0.395 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.652916e-01 | 0.437 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.497612e-01 | 0.347 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.416759e-01 | 0.466 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.028814e-01 | 0.519 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.920631e-01 | 0.308 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.129077e-01 | 0.505 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.304569e-01 | 0.366 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.016690e-01 | 0.396 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.988510e-01 | 0.302 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.733519e-01 | 0.428 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.756509e-01 | 0.425 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.176362e-01 | 0.498 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.544095e-01 | 0.450 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.016690e-01 | 0.396 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.001055e-01 | 0.301 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.110642e-01 | 0.507 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.853697e-01 | 0.545 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.853697e-01 | 0.545 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.116585e-01 | 0.385 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.116585e-01 | 0.385 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.116585e-01 | 0.385 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.842467e-01 | 0.546 | 1 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.643961e-01 | 0.438 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.604262e-01 | 0.337 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.791353e-01 | 0.554 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.005290e-01 | 0.522 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.544095e-01 | 0.450 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.062568e-01 | 0.296 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.354572e-01 | 0.271 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.413008e-01 | 0.355 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.351378e-01 | 0.475 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.133287e-01 | 0.504 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.328752e-01 | 0.273 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.853697e-01 | 0.545 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.853697e-01 | 0.545 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.107000e-01 | 0.386 | 0 | 0 |
| Hydroxycarboxylic acid-binding receptors | R-HSA-3296197 | 4.604262e-01 | 0.337 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.604262e-01 | 0.337 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.809347e-01 | 0.419 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.305728e-01 | 0.481 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.791353e-01 | 0.554 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.059591e-01 | 0.296 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 5.476521e-01 | 0.261 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.476521e-01 | 0.261 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.478939e-01 | 0.349 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.988510e-01 | 0.302 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.260272e-01 | 0.279 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 5.260272e-01 | 0.279 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.876936e-01 | 0.312 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.649608e-01 | 0.333 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.249431e-01 | 0.372 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.480826e-01 | 0.349 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.960520e-01 | 0.304 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.950763e-01 | 0.305 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.500894e-01 | 0.347 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.999807e-01 | 0.523 | 1 | 0 |
| Histamine receptors | R-HSA-390650 | 3.563946e-01 | 0.448 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.495478e-01 | 0.456 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.476521e-01 | 0.261 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.988510e-01 | 0.302 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.005762e-01 | 0.397 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.424381e-01 | 0.266 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.542901e-01 | 0.451 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.874142e-01 | 0.541 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.315780e-01 | 0.274 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.701317e-01 | 0.432 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.176362e-01 | 0.498 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.604262e-01 | 0.337 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.809347e-01 | 0.419 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.476521e-01 | 0.261 | 1 | 1 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.704660e-01 | 0.327 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.846448e-01 | 0.546 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.725686e-01 | 0.429 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.400406e-01 | 0.468 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.988510e-01 | 0.302 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.497245e-01 | 0.347 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.245133e-01 | 0.280 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.544095e-01 | 0.450 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.563946e-01 | 0.448 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.853697e-01 | 0.545 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.495478e-01 | 0.456 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.809347e-01 | 0.419 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.059591e-01 | 0.296 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.416078e-01 | 0.355 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.476521e-01 | 0.261 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.119740e-01 | 0.385 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.110642e-01 | 0.507 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.949294e-01 | 0.530 | 1 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.877635e-01 | 0.411 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.059591e-01 | 0.296 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.518906e-01 | 0.454 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.416078e-01 | 0.355 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.495478e-01 | 0.456 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.731449e-01 | 0.428 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.058279e-01 | 0.296 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.059591e-01 | 0.296 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.142865e-01 | 0.289 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.853697e-01 | 0.545 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 3.640995e-01 | 0.439 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.176362e-01 | 0.498 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.416078e-01 | 0.355 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.416078e-01 | 0.355 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.706944e-01 | 0.327 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.604262e-01 | 0.337 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.482701e-01 | 0.261 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.521881e-01 | 0.258 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.521881e-01 | 0.258 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.521881e-01 | 0.258 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 5.521881e-01 | 0.258 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 5.521881e-01 | 0.258 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.521881e-01 | 0.258 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.521881e-01 | 0.258 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.521881e-01 | 0.258 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.521881e-01 | 0.258 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.560929e-01 | 0.255 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.560929e-01 | 0.255 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.586671e-01 | 0.253 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.638243e-01 | 0.249 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.638243e-01 | 0.249 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.674974e-01 | 0.246 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.687592e-01 | 0.245 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.695895e-01 | 0.244 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.736022e-01 | 0.241 | 1 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.761690e-01 | 0.239 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.761690e-01 | 0.239 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.769829e-01 | 0.239 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.772078e-01 | 0.239 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 5.773115e-01 | 0.239 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 5.773115e-01 | 0.239 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.773115e-01 | 0.239 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.773115e-01 | 0.239 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.773115e-01 | 0.239 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.773115e-01 | 0.239 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.773115e-01 | 0.239 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.773115e-01 | 0.239 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.773115e-01 | 0.239 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.813754e-01 | 0.236 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.858289e-01 | 0.232 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.858289e-01 | 0.232 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.858289e-01 | 0.232 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.858289e-01 | 0.232 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.858289e-01 | 0.232 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.858289e-01 | 0.232 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.858289e-01 | 0.232 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.858289e-01 | 0.232 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.858289e-01 | 0.232 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.858289e-01 | 0.232 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.858289e-01 | 0.232 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.858289e-01 | 0.232 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.888802e-01 | 0.230 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.895629e-01 | 0.229 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.940169e-01 | 0.226 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.956657e-01 | 0.225 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.956657e-01 | 0.225 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.956657e-01 | 0.225 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.981137e-01 | 0.223 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.999601e-01 | 0.222 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.013862e-01 | 0.221 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.013862e-01 | 0.221 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.013862e-01 | 0.221 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.084321e-01 | 0.216 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.084321e-01 | 0.216 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.087757e-01 | 0.216 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.104227e-01 | 0.214 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.104227e-01 | 0.214 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.145678e-01 | 0.211 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.145678e-01 | 0.211 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.145678e-01 | 0.211 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.145678e-01 | 0.211 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.207857e-01 | 0.207 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.207857e-01 | 0.207 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.207857e-01 | 0.207 | 1 | 1 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.207857e-01 | 0.207 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.207857e-01 | 0.207 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.207857e-01 | 0.207 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.207857e-01 | 0.207 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.207857e-01 | 0.207 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.207857e-01 | 0.207 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.207857e-01 | 0.207 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.207857e-01 | 0.207 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.207857e-01 | 0.207 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.207857e-01 | 0.207 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.207857e-01 | 0.207 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.207857e-01 | 0.207 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.207857e-01 | 0.207 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 6.207857e-01 | 0.207 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.207857e-01 | 0.207 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.207857e-01 | 0.207 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.207857e-01 | 0.207 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.207857e-01 | 0.207 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.207857e-01 | 0.207 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.211454e-01 | 0.207 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.216727e-01 | 0.206 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.235291e-01 | 0.205 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.244102e-01 | 0.205 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.244102e-01 | 0.205 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.244102e-01 | 0.205 | 1 | 1 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.244102e-01 | 0.205 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.244102e-01 | 0.205 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.244102e-01 | 0.205 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.264133e-01 | 0.203 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.264133e-01 | 0.203 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.264133e-01 | 0.203 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.264133e-01 | 0.203 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.273829e-01 | 0.202 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.325842e-01 | 0.199 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.328643e-01 | 0.199 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.348657e-01 | 0.197 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.463894e-01 | 0.190 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.463894e-01 | 0.190 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.463894e-01 | 0.190 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.505479e-01 | 0.187 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.505479e-01 | 0.187 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.527940e-01 | 0.185 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.527940e-01 | 0.185 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.527940e-01 | 0.185 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.527940e-01 | 0.185 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.527940e-01 | 0.185 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.527940e-01 | 0.185 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.527940e-01 | 0.185 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.527940e-01 | 0.185 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.527940e-01 | 0.185 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.527940e-01 | 0.185 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.527940e-01 | 0.185 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.527940e-01 | 0.185 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.527940e-01 | 0.185 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.527940e-01 | 0.185 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.527940e-01 | 0.185 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.527940e-01 | 0.185 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.530460e-01 | 0.185 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.563646e-01 | 0.183 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.595104e-01 | 0.181 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.622594e-01 | 0.179 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.631673e-01 | 0.178 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.643198e-01 | 0.178 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.673361e-01 | 0.176 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.673361e-01 | 0.176 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.673361e-01 | 0.176 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.673361e-01 | 0.176 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.673361e-01 | 0.176 | 1 | 1 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.673361e-01 | 0.176 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.676148e-01 | 0.175 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.676148e-01 | 0.175 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.821023e-01 | 0.166 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.821023e-01 | 0.166 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.821023e-01 | 0.166 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.821023e-01 | 0.166 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.821023e-01 | 0.166 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.821023e-01 | 0.166 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.821023e-01 | 0.166 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.821023e-01 | 0.166 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.821023e-01 | 0.166 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.821023e-01 | 0.166 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.821023e-01 | 0.166 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.821023e-01 | 0.166 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.821023e-01 | 0.166 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.821023e-01 | 0.166 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.821023e-01 | 0.166 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.821023e-01 | 0.166 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.840640e-01 | 0.165 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.840640e-01 | 0.165 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.840640e-01 | 0.165 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.840640e-01 | 0.165 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.872680e-01 | 0.163 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.872680e-01 | 0.163 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.872680e-01 | 0.163 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.872680e-01 | 0.163 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.872680e-01 | 0.163 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.899610e-01 | 0.161 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.949702e-01 | 0.158 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.949702e-01 | 0.158 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.998797e-01 | 0.155 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.998797e-01 | 0.155 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.998977e-01 | 0.155 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.998977e-01 | 0.155 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.998977e-01 | 0.155 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.018793e-01 | 0.154 | 1 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.024440e-01 | 0.153 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.032146e-01 | 0.153 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.062070e-01 | 0.151 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.062070e-01 | 0.151 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.062070e-01 | 0.151 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.062070e-01 | 0.151 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.062070e-01 | 0.151 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.062070e-01 | 0.151 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.062070e-01 | 0.151 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.062070e-01 | 0.151 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.062070e-01 | 0.151 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.062265e-01 | 0.151 | 1 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.087191e-01 | 0.150 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.089382e-01 | 0.149 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.089382e-01 | 0.149 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.089382e-01 | 0.149 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.089382e-01 | 0.149 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.089382e-01 | 0.149 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.089382e-01 | 0.149 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.089382e-01 | 0.149 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.089382e-01 | 0.149 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.089382e-01 | 0.149 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.132498e-01 | 0.147 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.132498e-01 | 0.147 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.151201e-01 | 0.146 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.151201e-01 | 0.146 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.151201e-01 | 0.146 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.171973e-01 | 0.144 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.201367e-01 | 0.143 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.241788e-01 | 0.140 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.241788e-01 | 0.140 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.241788e-01 | 0.140 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.241788e-01 | 0.140 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 7.241788e-01 | 0.140 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.241788e-01 | 0.140 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.247456e-01 | 0.140 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.261293e-01 | 0.139 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.261293e-01 | 0.139 | 1 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.261778e-01 | 0.139 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.278817e-01 | 0.138 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.289846e-01 | 0.137 | 1 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.297378e-01 | 0.137 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.297378e-01 | 0.137 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.297378e-01 | 0.137 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.297378e-01 | 0.137 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.297378e-01 | 0.137 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.306351e-01 | 0.136 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.335102e-01 | 0.135 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.335102e-01 | 0.135 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.335102e-01 | 0.135 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.335102e-01 | 0.135 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.335102e-01 | 0.135 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.335102e-01 | 0.135 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.335102e-01 | 0.135 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.335102e-01 | 0.135 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.346467e-01 | 0.134 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.374509e-01 | 0.132 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.374509e-01 | 0.132 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.376439e-01 | 0.132 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.386662e-01 | 0.132 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.386662e-01 | 0.132 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.412117e-01 | 0.130 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.412117e-01 | 0.130 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.412117e-01 | 0.130 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.429789e-01 | 0.129 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.429789e-01 | 0.129 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.429789e-01 | 0.129 | 1 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.437592e-01 | 0.129 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.461139e-01 | 0.127 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.461139e-01 | 0.127 | 1 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.484263e-01 | 0.126 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.507184e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.507184e-01 | 0.125 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.560091e-01 | 0.121 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.560091e-01 | 0.121 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.560091e-01 | 0.121 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.560091e-01 | 0.121 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.560091e-01 | 0.121 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.560091e-01 | 0.121 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.560091e-01 | 0.121 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.560091e-01 | 0.121 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.560091e-01 | 0.121 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.560091e-01 | 0.121 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.560091e-01 | 0.121 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.560091e-01 | 0.121 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.560091e-01 | 0.121 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.560091e-01 | 0.121 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.571943e-01 | 0.121 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.573361e-01 | 0.121 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.573361e-01 | 0.121 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.573361e-01 | 0.121 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.573361e-01 | 0.121 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.573361e-01 | 0.121 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.573361e-01 | 0.121 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.573361e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.573361e-01 | 0.121 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.573361e-01 | 0.121 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.573361e-01 | 0.121 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.592984e-01 | 0.120 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.623391e-01 | 0.118 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.677555e-01 | 0.115 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.700546e-01 | 0.113 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.700546e-01 | 0.113 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.700546e-01 | 0.113 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.700546e-01 | 0.113 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.700546e-01 | 0.113 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.703852e-01 | 0.113 | 1 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.725838e-01 | 0.112 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.725838e-01 | 0.112 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.725838e-01 | 0.112 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.725838e-01 | 0.112 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.725838e-01 | 0.112 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.735339e-01 | 0.112 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.735339e-01 | 0.112 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.735339e-01 | 0.112 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.766098e-01 | 0.110 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.766098e-01 | 0.110 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.766098e-01 | 0.110 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.766098e-01 | 0.110 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.766098e-01 | 0.110 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.766098e-01 | 0.110 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 7.766098e-01 | 0.110 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.766098e-01 | 0.110 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.766098e-01 | 0.110 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.766098e-01 | 0.110 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.814662e-01 | 0.107 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.823526e-01 | 0.107 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.823526e-01 | 0.107 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.823526e-01 | 0.107 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.823526e-01 | 0.107 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.823526e-01 | 0.107 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.842119e-01 | 0.106 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.843092e-01 | 0.106 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.843092e-01 | 0.106 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.843092e-01 | 0.106 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.869880e-01 | 0.104 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.869880e-01 | 0.104 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.869880e-01 | 0.104 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.946720e-01 | 0.100 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.954722e-01 | 0.099 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.954722e-01 | 0.099 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.954722e-01 | 0.099 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.954722e-01 | 0.099 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.954722e-01 | 0.099 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.954722e-01 | 0.099 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.954722e-01 | 0.099 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.954722e-01 | 0.099 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.954722e-01 | 0.099 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.954722e-01 | 0.099 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.954722e-01 | 0.099 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.954722e-01 | 0.099 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.954722e-01 | 0.099 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.005824e-01 | 0.097 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.005824e-01 | 0.097 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.005824e-01 | 0.097 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.011881e-01 | 0.096 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.018651e-01 | 0.096 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.046304e-01 | 0.094 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.048885e-01 | 0.094 | 1 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.053175e-01 | 0.094 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.053175e-01 | 0.094 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.127429e-01 | 0.090 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.127429e-01 | 0.090 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.127429e-01 | 0.090 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.127429e-01 | 0.090 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.127429e-01 | 0.090 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.127429e-01 | 0.090 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.127429e-01 | 0.090 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.127429e-01 | 0.090 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.127429e-01 | 0.090 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.127429e-01 | 0.090 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.134010e-01 | 0.090 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.134010e-01 | 0.090 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.134010e-01 | 0.090 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.134010e-01 | 0.090 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.134010e-01 | 0.090 | 1 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.134010e-01 | 0.090 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.141926e-01 | 0.089 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.143890e-01 | 0.089 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.153546e-01 | 0.089 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.158116e-01 | 0.088 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.158116e-01 | 0.088 | 1 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.160139e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.254778e-01 | 0.083 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.254778e-01 | 0.083 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.254778e-01 | 0.083 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.262069e-01 | 0.083 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.262069e-01 | 0.083 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.262069e-01 | 0.083 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.262069e-01 | 0.083 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.267824e-01 | 0.083 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.268622e-01 | 0.083 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.268622e-01 | 0.083 | 1 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.285562e-01 | 0.082 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.285562e-01 | 0.082 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.285562e-01 | 0.082 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.285562e-01 | 0.082 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.285562e-01 | 0.082 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.285562e-01 | 0.082 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.285562e-01 | 0.082 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.285562e-01 | 0.082 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.285562e-01 | 0.082 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.285562e-01 | 0.082 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.285562e-01 | 0.082 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.285562e-01 | 0.082 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.304387e-01 | 0.081 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.321645e-01 | 0.080 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.359126e-01 | 0.078 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.359126e-01 | 0.078 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.359126e-01 | 0.078 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.359126e-01 | 0.078 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.368466e-01 | 0.077 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.368466e-01 | 0.077 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.405931e-01 | 0.075 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.405931e-01 | 0.075 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.405931e-01 | 0.075 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.405931e-01 | 0.075 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.418191e-01 | 0.075 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.430350e-01 | 0.074 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.430350e-01 | 0.074 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.430350e-01 | 0.074 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.430350e-01 | 0.074 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.430350e-01 | 0.074 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.430350e-01 | 0.074 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.450558e-01 | 0.073 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.450558e-01 | 0.073 | 1 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.451473e-01 | 0.073 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.451473e-01 | 0.073 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.451473e-01 | 0.073 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.451473e-01 | 0.073 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.451473e-01 | 0.073 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 8.475410e-01 | 0.072 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.475410e-01 | 0.072 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.481238e-01 | 0.072 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.481238e-01 | 0.072 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.486632e-01 | 0.071 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.501968e-01 | 0.070 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.539273e-01 | 0.069 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.539273e-01 | 0.069 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.544535e-01 | 0.068 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.548578e-01 | 0.068 | 1 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.562918e-01 | 0.067 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.562918e-01 | 0.067 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.562918e-01 | 0.067 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.562918e-01 | 0.067 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.562918e-01 | 0.067 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.575936e-01 | 0.067 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.575936e-01 | 0.067 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.575936e-01 | 0.067 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.575936e-01 | 0.067 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.636147e-01 | 0.064 | 1 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.637688e-01 | 0.064 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.637688e-01 | 0.064 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.670365e-01 | 0.062 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.670365e-01 | 0.062 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.678991e-01 | 0.062 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.684297e-01 | 0.061 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.684297e-01 | 0.061 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.684297e-01 | 0.061 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.684297e-01 | 0.061 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.701894e-01 | 0.060 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.730064e-01 | 0.059 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.759011e-01 | 0.058 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 8.759011e-01 | 0.058 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.759011e-01 | 0.058 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.759011e-01 | 0.058 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.759011e-01 | 0.058 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.759011e-01 | 0.058 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.759011e-01 | 0.058 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.759011e-01 | 0.058 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.759011e-01 | 0.058 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.762752e-01 | 0.057 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.777044e-01 | 0.057 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.795431e-01 | 0.056 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.795431e-01 | 0.056 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.795431e-01 | 0.056 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.795431e-01 | 0.056 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.795431e-01 | 0.056 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.795431e-01 | 0.056 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.795431e-01 | 0.056 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.795431e-01 | 0.056 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.795431e-01 | 0.056 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.836177e-01 | 0.054 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.841216e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.842175e-01 | 0.053 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.842175e-01 | 0.053 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.842175e-01 | 0.053 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.842175e-01 | 0.053 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.842175e-01 | 0.053 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.843671e-01 | 0.053 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.843671e-01 | 0.053 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.865584e-01 | 0.052 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.897183e-01 | 0.051 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.897183e-01 | 0.051 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.897183e-01 | 0.051 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.897183e-01 | 0.051 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.897183e-01 | 0.051 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.897183e-01 | 0.051 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.897183e-01 | 0.051 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.897183e-01 | 0.051 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.897183e-01 | 0.051 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.897183e-01 | 0.051 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.915834e-01 | 0.050 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 8.920152e-01 | 0.050 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.920152e-01 | 0.050 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.920152e-01 | 0.050 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.920152e-01 | 0.050 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.920152e-01 | 0.050 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.924416e-01 | 0.049 | 1 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.938983e-01 | 0.049 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.946997e-01 | 0.048 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.959809e-01 | 0.048 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.979791e-01 | 0.047 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.990346e-01 | 0.046 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.990346e-01 | 0.046 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.990346e-01 | 0.046 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.990346e-01 | 0.046 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.990346e-01 | 0.046 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.990346e-01 | 0.046 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 8.990346e-01 | 0.046 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.990346e-01 | 0.046 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.991593e-01 | 0.046 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.993223e-01 | 0.046 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.993223e-01 | 0.046 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.995636e-01 | 0.046 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.029689e-01 | 0.044 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.031826e-01 | 0.044 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.040330e-01 | 0.044 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.061662e-01 | 0.043 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.061662e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.061662e-01 | 0.043 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.075644e-01 | 0.042 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.075644e-01 | 0.042 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.075644e-01 | 0.042 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.075644e-01 | 0.042 | 0 | 0 |
| Translation | R-HSA-72766 | 9.090440e-01 | 0.041 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.125728e-01 | 0.040 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.151754e-01 | 0.038 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.151754e-01 | 0.038 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.151754e-01 | 0.038 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 9.153740e-01 | 0.038 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.153740e-01 | 0.038 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.153740e-01 | 0.038 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.153740e-01 | 0.038 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.167234e-01 | 0.038 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.167234e-01 | 0.038 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.181835e-01 | 0.037 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.185672e-01 | 0.037 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.185672e-01 | 0.037 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.185672e-01 | 0.037 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.185672e-01 | 0.037 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.188505e-01 | 0.037 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.202930e-01 | 0.036 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.225243e-01 | 0.035 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.225243e-01 | 0.035 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.225243e-01 | 0.035 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.225243e-01 | 0.035 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.241733e-01 | 0.034 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.241733e-01 | 0.034 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.241733e-01 | 0.034 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.241733e-01 | 0.034 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.241733e-01 | 0.034 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.241733e-01 | 0.034 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.267231e-01 | 0.033 | 1 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.290707e-01 | 0.032 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.290707e-01 | 0.032 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.290707e-01 | 0.032 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.290707e-01 | 0.032 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.290707e-01 | 0.032 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.290707e-01 | 0.032 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.294139e-01 | 0.032 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.294139e-01 | 0.032 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.294139e-01 | 0.032 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.294139e-01 | 0.032 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.334429e-01 | 0.030 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.343107e-01 | 0.030 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.343107e-01 | 0.030 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.343107e-01 | 0.030 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.350644e-01 | 0.029 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.350644e-01 | 0.029 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.350644e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.350644e-01 | 0.029 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.350644e-01 | 0.029 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.350644e-01 | 0.029 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.355461e-01 | 0.029 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.374071e-01 | 0.028 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.380592e-01 | 0.028 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.388843e-01 | 0.027 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.388843e-01 | 0.027 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.405520e-01 | 0.027 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.405520e-01 | 0.027 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.405520e-01 | 0.027 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.405520e-01 | 0.027 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.418580e-01 | 0.026 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.418890e-01 | 0.026 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.431545e-01 | 0.025 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.433821e-01 | 0.025 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.439177e-01 | 0.025 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.454353e-01 | 0.024 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.454982e-01 | 0.024 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.454982e-01 | 0.024 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.455761e-01 | 0.024 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.455761e-01 | 0.024 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.455761e-01 | 0.024 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.455761e-01 | 0.024 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.456554e-01 | 0.024 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.471398e-01 | 0.024 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.471398e-01 | 0.024 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.471398e-01 | 0.024 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.471398e-01 | 0.024 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.474570e-01 | 0.023 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.488981e-01 | 0.023 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.501758e-01 | 0.022 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.501758e-01 | 0.022 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.501758e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.501758e-01 | 0.022 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.501758e-01 | 0.022 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.508578e-01 | 0.022 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.508578e-01 | 0.022 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.508578e-01 | 0.022 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.521269e-01 | 0.021 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.533114e-01 | 0.021 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.543871e-01 | 0.020 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.543871e-01 | 0.020 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.574247e-01 | 0.019 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.575579e-01 | 0.019 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.582426e-01 | 0.019 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.582426e-01 | 0.019 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.582426e-01 | 0.019 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.583697e-01 | 0.018 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.605706e-01 | 0.017 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.606146e-01 | 0.017 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.606317e-01 | 0.017 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.617725e-01 | 0.017 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.617725e-01 | 0.017 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.617725e-01 | 0.017 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.617725e-01 | 0.017 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.617725e-01 | 0.017 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.623734e-01 | 0.017 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.631216e-01 | 0.016 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.650042e-01 | 0.015 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.659920e-01 | 0.015 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.659920e-01 | 0.015 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.660153e-01 | 0.015 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.660153e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.660153e-01 | 0.015 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.667578e-01 | 0.015 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.676917e-01 | 0.014 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.679628e-01 | 0.014 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.684263e-01 | 0.014 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.697709e-01 | 0.013 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.697709e-01 | 0.013 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.697709e-01 | 0.013 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.706715e-01 | 0.013 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.706715e-01 | 0.013 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.706715e-01 | 0.013 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.719778e-01 | 0.012 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.729242e-01 | 0.012 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.731270e-01 | 0.012 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.731513e-01 | 0.012 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.731513e-01 | 0.012 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.731513e-01 | 0.012 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.731513e-01 | 0.012 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.731513e-01 | 0.012 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.745466e-01 | 0.011 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.745466e-01 | 0.011 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.747628e-01 | 0.011 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.752746e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.754215e-01 | 0.011 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.775000e-01 | 0.010 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.775000e-01 | 0.010 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.775000e-01 | 0.010 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.794027e-01 | 0.009 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.794027e-01 | 0.009 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.794027e-01 | 0.009 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.794027e-01 | 0.009 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.798614e-01 | 0.009 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.801664e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.810797e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.810797e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.811447e-01 | 0.008 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.811459e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.811459e-01 | 0.008 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.813274e-01 | 0.008 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.813274e-01 | 0.008 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.813274e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.813760e-01 | 0.008 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.823907e-01 | 0.008 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.826895e-01 | 0.008 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.826895e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.826895e-01 | 0.008 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.826895e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.826895e-01 | 0.008 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.826895e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.826895e-01 | 0.008 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.827394e-01 | 0.008 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.839550e-01 | 0.007 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.841994e-01 | 0.007 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.846486e-01 | 0.007 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.847779e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.858526e-01 | 0.006 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.862814e-01 | 0.006 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.866274e-01 | 0.006 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.867595e-01 | 0.006 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.867595e-01 | 0.006 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.868205e-01 | 0.006 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.881753e-01 | 0.005 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.884684e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.890373e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.891433e-01 | 0.005 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.898438e-01 | 0.004 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.898756e-01 | 0.004 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.907031e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.919522e-01 | 0.004 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.919920e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.925513e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.929152e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.931067e-01 | 0.003 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.933791e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.934104e-01 | 0.003 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.934727e-01 | 0.003 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.934727e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.938200e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.945309e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.945406e-01 | 0.002 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.945406e-01 | 0.002 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.953294e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.955529e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.956808e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.962931e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.964858e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.967833e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.970833e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.975333e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.976147e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.977422e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.979163e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.979163e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.981085e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.981827e-01 | 0.001 | 1 | 0 |
| Xenobiotics | R-HSA-211981 | 9.982687e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.982687e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.984042e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.985496e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.986725e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.987044e-01 | 0.001 | 1 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.987496e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.989560e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.991829e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.992196e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.992249e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.992571e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.993041e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.993578e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.994496e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.995347e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.996158e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.996527e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997055e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.997294e-01 | 0.000 | 1 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.997360e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997566e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997597e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997756e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.997781e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997944e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998624e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998907e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999070e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999149e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999221e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999348e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999647e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999668e-01 | 0.000 | 1 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999745e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999822e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999838e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999847e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999856e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999868e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999868e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999873e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999890e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999919e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999931e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999945e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999951e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999955e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999976e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999980e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999986e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999988e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999994e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999994e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999995e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999997e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999997e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |